
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />






  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>



    <style>


  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>






            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />


        <title>
            Postoperative radiotherapy for thymic epithelial tumors: a narrative review - PMC
        </title>




  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B9BC48F236CA31D9BC40007113B82.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />

    <link rel="preconnect" href="https://www.google-analytics.com" />


        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />


    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="mediastinum">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11330913/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Mediastinum">
<meta name="citation_title" content="Postoperative radiotherapy for thymic epithelial tumors: a narrative review">
<meta name="citation_author" content="Noriko Kishi">
<meta name="citation_author_institution" content="Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan;">
<meta name="citation_author" content="Yukinori Matsuo">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka, Japan">
<meta name="citation_publication_date" content="2024 Jan 10">
<meta name="citation_volume" content="8">
<meta name="citation_firstpage" content="40">
<meta name="citation_doi" content="10.21037/med-23-38">
<meta name="citation_pmid" content="39161587">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11330913/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11330913/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11330913/pdf/med-08-40.pdf">
<meta name="description" content="Thymic epithelial tumors (TETs), including thymomas and thymic carcinomas, are rare mediastinal tumors. Surgical resection is the treatment strategy for resectable TETs, and postoperative radiotherapy (PORT) is administered to improve local control ...">
<meta name="og:title" content="Postoperative radiotherapy for thymic epithelial tumors: a narrative review">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Thymic epithelial tumors (TETs), including thymomas and thymic carcinomas, are rare mediastinal tumors. Surgical resection is the treatment strategy for resectable TETs, and postoperative radiotherapy (PORT) is administered to improve local control ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11330913/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">



    </head>
    <body >

    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>





<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>






















        <button
            type="button"


    class="usa-accordion__button usa-banner__button












           "
    aria-expanded="false"
    aria-controls="gov-banner-default"

    data-testid="storybook-django-banner"

    >




                    <span class="usa-banner__button-text">Here's how you know</span>





            </button>



            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>








<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->





















        <button
            type="button"


    class="usa-menu-btn ncbi-header__hamburger-button












           "


    aria-label="Show menu"
    data-testid="navMenuButton"

    >




                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>





            </button>





                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">

                        <!-- Desktop search button -->





















        <button
            type="button"


    class="usa-button











           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >








    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >

        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search





            </button>





                    <!-- Desktop login dropdown -->

                        <div class="ncbi-header__login-dropdown">





















        <button
            type="button"


    class="usa-button











           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >








    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >

        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->




    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>

        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->




    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>

        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>







            </button>




                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>

                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->










    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >



            Dashboard



    </a>


                                    </li>

                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->










    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >



            Publications



    </a>


                                    </li>

                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->










    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >



            Account settings



    </a>


                                    </li>

                                <li class="usa-nav__submenu-item">





















        <button
            type="button"


    class="usa-button











           usa-button--outline ncbi-header__login-dropdown-logout-button
           "



    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >



        Log out




            </button>



                                </li>
                            </ul>
                        </div>

                </div>

        </div>
    </div>

    <!-- Search panel -->

        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"

                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"

                               placeholder="Search NCBI"

                           type="search"
                           value="" />





















        <button
            type="submit"


    class="usa-button












           "





    >




                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>





            </button>



                </form>


            </div>
        </div>


    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->





















        <button
            type="button"


    class="usa-nav__close ncbi-nav__close-button












           "


    aria-label="Close navigation menu"
    data-testid="navCloseButton"

    >




            <img src="/static/img/usa-icons/close.svg" alt="Close" />





            </button>





            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"

                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"

                           placeholder="Search NCBI"

                       name="term" />






















        <button
            type="submit"


    class="usa-button












           "





    >




                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />





            </button>



            </form>




        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->



            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">

                        <li class="usa-nav__primary-item">










    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >



            Dashboard



    </a>


                        </li>

                        <li class="usa-nav__primary-item">










    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >



            Publications



    </a>


                        </li>

                        <li class="usa-nav__primary-item">










    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >



            Account settings



    </a>


                        </li>

                </ul>
            </div>























        <button
            type="button"


    class="usa-button











           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "



    data-testid="mobileLoginButton"
    data-mobile-login-button
    >



        Log in




            </button>



    </nav>
</header>





<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">



<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>

                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>

                    </li>
                    <li>

                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>

                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>








  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11330913">







<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>

                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.21037/med-23-38"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>


                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/med-08-40.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>

                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11330913%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>

                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11330913/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11330913/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>

                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>


<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11330913/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >


                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-mediastinum.png" alt="Mediastinum logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Mediastinum" title="Link to Mediastinum" shape="default" href="https://med.amegroups.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Mediastinum</button></div>. 2024 Jan 10;8:40. doi: <a href="https://doi.org/10.21037/med-23-38" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.21037/med-23-38</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Mediastinum%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mediastinum%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Mediastinum%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Mediastinum%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Postoperative radiotherapy for thymic epithelial tumors: a narrative review</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kishi%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Noriko Kishi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Noriko Kishi</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kishi%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Noriko Kishi</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Matsuo%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yukinori Matsuo</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yukinori Matsuo</span></h3>
<div class="p">
<sup>2</sup>Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Matsuo%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yukinori Matsuo</span></a>
</div>
</div>
<sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan;</div>
<div id="aff2">
<sup>2</sup>Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka, Japan</div>
<div class="author-notes p">
<div class="fn" id="afn1"><p><em>Contributions:</em> (I) Conception and design: N Kishi; (II) Administrative support: Y Matsuo; (III) Provision of study materials or patients: N Kishi; (IV) Collection and assembly of data: N Kishi; (V) Data analysis and interpretation: N Kishi; (VI) Manuscript writing: Both authors; (VII) Final approval of manuscript: Both authors.</p></div>
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline"><em>Correspondence to:</em> Noriko Kishi, MD. Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. Email: <span>kishin@kuhp.kyoto-u.ac.jp</span>.</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2023 Sep 20; Accepted 2023 Nov 21; Collection date 2024.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>2024 Mediastinum. All rights reserved.</div>
<p><em>Open Access Statement:</em> This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by-nc-nd/4.0</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11330913  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39161587/" class="usa-link">39161587</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background and Objective</h3>
<p>Thymic epithelial tumors (TETs), including thymomas and thymic carcinomas, are rare mediastinal tumors. Surgical resection is the treatment strategy for resectable TETs, and postoperative radiotherapy (PORT) is administered to improve local control in patients with a high risk of recurrence. The rarity of TETs has led to a lack of randomized controlled trials, and the current indications for PORT rely largely on retrospective studies. This review analyzes the literature on TETs, highlighting PORT, to guide current research and future investigations.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p>Studies that focused on TETs, addressed topics on PORT, and had English abstracts accessible online were eligible for inclusion in our review. We excluded case reports or review articles, articles written in languages other than English, articles published &gt;30 years ago, and articles concerning thymic neuroendocrine tumors.</p></section><section id="sec3"><h3 class="pmc_sec_title">Key Content and Findings</h3>
<p>Masaoka or Masaoka-Koga staging, World Health Organization (WHO) histological subtype, and resection status indicate PORT in resected TETs. Current literature suggests that PORT does not improve overall survival in stage I–IIA TETs, with inconsistent results for stage IIB–III TETs. Patients with a higher risk, such as carcinomas or WHO type B, might benefit from PORT if they do not develop distant metastasis. Determining which patients will benefit most from PORT requires further investigation. For recurrent TETs, the significance of applying PORT is unclear because available data are limited. Given the long-term survival of TETs, late toxicities, including radiation pneumonitis, radiation-induced cardiotoxicities, and secondary malignancies, must be addressed. Proton beam radiotherapy might reduce toxicities by sparing organs at risk compared to conventional photon beam radiotherapy. The use of high-precision radiation therapy, along with emerging immunotherapy, targeted therapy, and minimally invasive surgery, could improve TET outcomes.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p>This review consolidates the literature on PORT for TETs, factoring in the Masaoka-Koga staging, WHO histological subtypes, and resection status. Varying results regarding PORT efficacy have led to an undefined strategy for stage IIB–III TETs. Although advanced radiotherapy techniques promise to reduce radiation-induced toxicities, further research is needed to investigate the efficacy of PORT and combination therapy.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords: </strong> Postoperative radiotherapy, thymic carcinoma, thymic cancer, thymic epithelial tumors (TET)</p></section></section><section id="sec5"><h2 class="pmc_sec_title">Introduction</h2>
<section id="sec6"><h3 class="pmc_sec_title">Background</h3>
<p>Thymic epithelial tumors (TETs) are rare primary tumors originating from the anterior mediastinum and include thymomas and thymic carcinomas. The incidence of thymomas is 1.5 cases per million people, and that of thymic carcinoma is 0.3 cases per million people (<a href="#r1" class="usa-link" aria-describedby="r1">1</a>,<a href="#r2" class="usa-link" aria-describedby="r2">2</a>). Thymomas have a good prognosis with a 5-year overall survival (OS) rate of 90%, whereas that of thymic carcinomas is 55%, and a higher stage is associated with worse OS (<a href="#r3" class="usa-link" aria-describedby="r3">3</a>-<a href="#r6" class="usa-link" aria-describedby="r6">6</a>).</p>
<p>The Masaoka-Koga staging system has been commonly used for management determination and prognosis estimation of TETs (<a href="#r7" class="usa-link" aria-describedby="r7">7</a>,<a href="#r8" class="usa-link" aria-describedby="r8">8</a>). It focuses on the local invasive extent of the primary tumor (stages I–III), and pleural, pericardial, lymphogenous, or hematogenous metastases are all included in stage IV, as TETs spread locally and rarely develop lymphatic dissemination. Surgical resection is the main treatment strategy for stages I–III and IV TETs.</p>
<p>Pathological findings are closely associated with the prognosis of TET and are heterogeneous. According to the fifth edition of the World Health Organization (WHO) classification of the thymus and mediastinum, TETs are categorized as type A thymoma, type AB thymoma, thymoma type B1-B2-B3, several other minor thymoma subtypes, and carcinomas, including squamous cell carcinoma and adenocarcinoma (<a href="#r9" class="usa-link" aria-describedby="r9">9</a>); 10-year OS for each subtype were 100, 100, 85, 85, 65, and 40% for type A, AB, B1, B2, and B3 thymomas, and thymic carcinomas, respectively (<a href="#r10" class="usa-link" aria-describedby="r10">10</a>,<a href="#r11" class="usa-link" aria-describedby="r11">11</a>). Geographic differences exist in the frequency of WHO histological subtypes, which impact recurrence (<a href="#r12" class="usa-link" aria-describedby="r12">12</a>).</p>
<p>When patients with TETs undergo surgical resection, postoperative radiotherapy (PORT) is often administered to improve local control, depending on the pathological findings of the stage and the residual tumor (<a href="#r13" class="usa-link" aria-describedby="r13">13</a>).</p></section><section id="sec7"><h3 class="pmc_sec_title">Rationale and knowledge gap</h3>
<p>Owing to the rarity of TETs, no randomized controlled trials (RCTs) have been conducted to confirm the efficacy of PORT in TETs, and the current evidence levels are not high and are mainly based on retrospective studies. According to the National Comprehensive Cancer Network guidelines, completely resected Masaoka-Koga stage I thymomas do not require adjuvant therapy, whereas PORT is administered for TETs with microscopic (R1) or macroscopic (R2) residual tumors (<a href="#r13" class="usa-link" aria-describedby="r13">13</a>). For completely resected stage II–IV TETs, the guidelines recommend discussion by a multidisciplinary tumor board (MTB) to determine the patient’s treatment strategy because the efficacy of PORT in this area remains controversial.</p>
<p>The Réseau Tumeurs Thymiques et Cancer (RYTHMIC), a nationwide network for TETs in France, has prospectively gathered data to determine whether decisions on PORT made at the MTBs align with RYTHMIC guidelines and whether they are ultimately implemented in patient care (<a href="#r14" class="usa-link" aria-describedby="r14">14</a>). Among 241 patients with stage I–III disease, the MTB’s decision regarding PORT was not made in accordance with the ESMO/RYTHMIC guidelines in 20 patients. When the MTB recommended PORT in cases where the guidelines would have advised against it, a clear explanation for the inconsistency with the guidelines was not found; however, the cases were stage II thymomas with WHO type B2 or stage IIA thymomas with WHO type AB thymomas. Thus, the efficacy of PORT in TETs for these subjects could be considered a gray zone in the guidelines, where different MTBs would make different decisions.</p></section><section id="sec8"><h3 class="pmc_sec_title">Objective</h3>
<p>This narrative review aimed to evaluate and summarize the current literature regarding PORT for TETs in terms of indications for PORT, radiotherapy techniques, and toxicities. This review sheds light on this understudied area by providing information on the current ongoing trials and recommendations for future research. We present this article in accordance with the Narrative Review reporting checklist (available at <a href="https://med.amegroups.com/article/view/10.21037/med-23-38/rc" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://med.amegroups.com/article/view/10.21037/med-23-38/rc</a>).</p></section></section><section id="sec9"><h2 class="pmc_sec_title">Methods</h2>
<p>A summary of the search strategies is provided in <a href="#t1" class="usa-link"><em>Table 1</em></a>. N.K. developed and executed the PubMed search on August 5th, 2023. The reproducible search strategies for creating a narrative review are presented in <a href="#t2" class="usa-link"><em>Table 2</em></a>. The studies included in the review met the following eligibility criteria: (I) articles focusing on TETs; (II) articles that included topics on PORT; and (III) articles with English abstracts available online. The exclusion criteria were as follows: (I) case reports or review articles; (II) articles written in languages other than English; and (III) articles on thymic neuroendocrine tumors.</p>
<section class="tw xbox font-sm" id="t1"><h3 class="obj_head">Table 1. Search strategy summary.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="37.02%" span="1">
<col width="62.98%" span="1">
<thead><tr>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Items</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Specification</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Date of search (specified to date, month and year)</td>
<td valign="top" align="left" rowspan="1" colspan="1">August 5th, 2023</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Databases and other sources searched</td>
<td valign="top" align="left" rowspan="1" colspan="1">PubMed</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Search terms used</td>
<td valign="top" align="left" rowspan="1" colspan="1">radiotherapy, adjuvant, postoperative, thymic, thymoma</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Timeframe</td>
<td valign="top" align="left" rowspan="1" colspan="1">Since August 1st, 1992, until August 5th, 2023</td>
</tr>
<tr>
<td rowspan="8" valign="top" align="left" scope="row" colspan="1">Inclusion and exclusion criteria</td>
<td valign="top" align="left" rowspan="1" colspan="1">Inclusion criteria</td>
</tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">   (I) Articles on thymic epithelial tumors excluding thymic neuroendocrine tumor</td></tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">   (II) Articles on postoperative radiotherapy</td></tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">Exclusion criteria</td></tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">   (I) Articles written in non-English language</td></tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">   (II) Case reports, review articles, or guidelines</td></tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">   (III) Articles published &gt;30 years ago</td></tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">   (IV) Pre-clinical studies</td></tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Selection process</td>
<td valign="top" align="left" rowspan="1" colspan="1">N.K. conducted the selection independently and Y.M. reviewed the process</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="t2"><h3 class="obj_head">Table 2. Search strategy to create a narrative review (date of search: August 5th, 2023).</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="10.18%" span="1">
<col width="76.22%" span="1">
<col width="13.6%" span="1">
<thead><tr>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Search</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Query</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Items</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="2" valign="top" align="left" scope="row" colspan="1">#1</td>
<td valign="top" align="left" rowspan="1" colspan="1">Has abstract</td>
<td rowspan="2" valign="top" align="left" colspan="1">24,918,516</td>
</tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">“hasabstract” (All Fields)</td></tr>
<tr>
<td rowspan="2" valign="top" align="left" scope="row" colspan="1">#2</td>
<td valign="top" align="left" rowspan="1" colspan="1">Adjuvant radiotherapy OR Postoperative radiotherapy</td>
<td rowspan="2" valign="top" align="left" colspan="1">425,765</td>
</tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">(“radiotherapy, adjuvant”(MeSH Terms) OR (“radiotherapy”(All Fields) AND “adjuvant”(All Fields)) OR “adjuvant radiotherapy”(All Fields) OR (“adjuvant”(All Fields) AND “radiotherapy”(All Fields))) OR ((“postoperative period”(MeSH Terms) OR (“postoperative”(All Fields) AND “period”(All Fields)) OR “postoperative period”(All Fields) OR “postop”(All Fields) OR “postoperative”(All Fields) OR “postoperatively”(All Fields) OR “postoperatives”(All Fields)) AND (“radiotherapy”(MeSH Terms) OR “radiotherapy”(All Fields) OR “radiotherapies”(All Fields) OR “radiotherapy”(MeSH Subheading) OR “radiotherapy s”(All Fields)))</td></tr>
<tr>
<td rowspan="2" valign="top" align="left" scope="row" colspan="1">#3</td>
<td valign="top" align="left" rowspan="1" colspan="1">Thymic (ti) OR Thymoma (ti)</td>
<td rowspan="2" valign="top" align="left" colspan="1">16,097</td>
</tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">“Thymic”(Title) OR “Thymoma”(Title)</td></tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">#4</td>
<td valign="top" align="left" rowspan="1" colspan="1">#1 AND #2 AND #3</td>
<td valign="top" align="left" rowspan="1" colspan="1">488</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec10"><h2 class="pmc_sec_title">Indications for PORT</h2>
<p>One hundred eighty-four articles were identified in the search (<a href="#f1" class="usa-link"><em>Figure 1</em></a>). As no RCTs have assessed the efficacy of PORT, established rationales are based on retrospective studies of large databases. Although multi- or single-institutional retrospective studies have smaller sample sizes than large database studies, they can offer more detailed results. We review both types of studies and highlight their strengths.</p>
<figure class="fig xbox font-sm" id="f1"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11330913_med-08-40-f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11330913/5fa9aea60382/med-08-40-f1.jpg" loading="lazy" height="522" width="701" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flow chart for literature search and selection.</p></figcaption></figure><section id="sec11"><h3 class="pmc_sec_title">Resected TET</h3>
<p>Three pathological indications for PORT in resectable TETs have been discussed in the literature: pathological staging, WHO classification of histological subtypes, and resectional status (margin status).</p>
<section id="sec12"><h4 class="pmc_sec_title">Masaoka or Masaoka-Koga staging</h4>
<p>The Masaoka or Masaoka-Koga staging system has been widely used in pathological staging to determine the indications for PORT in TETs. In contrast, the International Thymic Malignancy Interest Group (ITMIG), European Society of Thoracic Surgeons, Japanese Association of Research in Thymus, and Chinese Alliance for Research on Thymomas developed an international database, which resulted in the development of the TNM stage classification. It provides information on lymphatic involvement and tumor dissemination in addition to tumor invasion extent, and is comparable or superior in grouping TETs for predicting prognosis and guiding clinical management (<a href="#r15" class="usa-link" aria-describedby="r15">15</a>-<a href="#r17" class="usa-link" aria-describedby="r17">17</a>). However, previous reports on PORT were largely based on Masaoka or Masaoka-Koga staging, and a paradigm shift is occurring from the traditional Masaoka-Koga system to a TNM system. In this section, we outline the benefits of PORT according to the Masaoka or Masaoka-Koga stages. In <a href="#t3" class="usa-link"><em>Table 3</em></a>, we present previous database studies that assessed the efficacy of PORT on OS, which have yielded conflicting results.</p>
<section class="tw xbox font-sm" id="t3"><h5 class="obj_head">Table 3. Previous database studies assessing the efficacy of postoperative radiotherapy on overall survival.</h5>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="13.03%" span="1">
<col width="6.5%" span="1">
<col width="6.5%" span="1">
<col width="5.69%" span="1">
<col width="7.31%" span="1">
<col width="6.5%" span="1">
<col width="4.87%" span="1">
<col width="12.2%" span="1">
<col width="11.38%" span="1">
<col width="6.5%" span="1">
<col width="19.52%" span="1">
<thead>
<tr>
<th rowspan="2" valign="middle" align="left" scope="col" style="border-bottom: solid 0.50pt" colspan="1">Authors</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-bottom: solid 0.50pt" colspan="1">N</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-bottom: solid 0.50pt" colspan="1">Primary</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-bottom: solid 0.50pt" colspan="1">Stage</th>
<th rowspan="2" valign="middle" align="center" scope="col" style="border-bottom: solid 0.50pt" colspan="1">Database</th>
<th valign="middle" colspan="5" align="center" scope="colgroup" style="border-bottom: solid 0.50pt" rowspan="1">Masaoka or Masaoka-Koga staging</th>
<th rowspan="2" valign="middle" align="center" scope="col" colspan="1">5-year OS in PORT <em>vs.</em> no PORT in stage II–IV</th>
</tr>
<tr>
<th valign="middle" colspan="1" align="center" scope="colgroup" style="border-top: solid 0.50pt" rowspan="1">I</th>
<th valign="middle" align="center" scope="col" style="border-top: solid 0.50pt" rowspan="1" colspan="1">IIA</th>
<th valign="middle" align="center" scope="col" style="border-top: solid 0.50pt" rowspan="1" colspan="1">IIB</th>
<th valign="middle" align="center" scope="col" style="border-top: solid 0.50pt" rowspan="1" colspan="1">III</th>
<th valign="middle" align="center" scope="col" style="border-top: solid 0.50pt" rowspan="1" colspan="1">IV</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Fernandes <em>et al.</em> (<a href="#r18" class="usa-link" aria-describedby="r18">18</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,334</td>
<td valign="top" align="center" rowspan="1" colspan="1">Car</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td colspan="2" valign="top" align="center" rowspan="1">NS (I–IIA)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td colspan="2" valign="top" align="center" rowspan="1">S (III–IV)</td>
<td valign="top" align="center" rowspan="1" colspan="1">Median, 134 <em>vs.</em> 115 months (IIB)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Patel <em>et al.</em> (<a href="#r19" class="usa-link" aria-describedby="r19">19</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,464</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td colspan="3" valign="top" align="center" rowspan="1">S (II–III)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">64% <em>vs.</em> 53% (II–III)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Weksler <em>et al.</em> (<a href="#r20" class="usa-link" aria-describedby="r20">20</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">476</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">III</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">Median, 127 <em>vs.</em>105 months</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mariano <em>et al.</em> (<a href="#r21" class="usa-link" aria-describedby="r21">21</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">171</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">BCCAR</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td colspan="2" valign="top" align="center" rowspan="1">NS (II)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ruffini <em>et al.</em> (<a href="#r22" class="usa-link" aria-describedby="r22">22</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2,265</td>
<td valign="top" align="center" rowspan="1" colspan="1">Car</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">ESTS</td>
<td colspan="5" valign="top" align="center" rowspan="1">S</td>
<td valign="top" align="center" rowspan="1" colspan="1">69% <em>vs.</em> 61%</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Omasa <em>et al.</em> (<a href="#r23" class="usa-link" aria-describedby="r23">23</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,265</td>
<td valign="top" align="center" rowspan="1" colspan="1">TET</td>
<td valign="top" align="center" rowspan="1" colspan="1">II–III</td>
<td valign="top" align="center" rowspan="1" colspan="1">JART</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td colspan="2" valign="top" align="center" rowspan="1">NS (II)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">97% <em>vs</em>. 96% (II, Thy)<br>93% <em>vs</em>. 90% (III, Thy)<br>91% <em>vs</em>. 87% (II, Car)<br>65% <em>vs</em>. 64% (III, Car)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hishida <em>et al.</em> (<a href="#r24" class="usa-link" aria-describedby="r24">24</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">306</td>
<td valign="top" align="center" rowspan="1" colspan="1">Car</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">JART</td>
<td colspan="5" valign="top" align="center" rowspan="1">NS (I–IV)</td>
<td valign="top" align="center" rowspan="1" colspan="1">78% <em>vs.</em> 74%</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lim <em>et al.</em> (<a href="#r25" class="usa-link" aria-describedby="r25">25</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">529</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">IIB–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td valign="top" align="center" rowspan="1" colspan="1">S</td>
<td valign="top" align="center" rowspan="1" colspan="1">S</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td rowspan="2" valign="top" align="left" scope="row" colspan="1">Fu <em>et al.</em> (<a href="#r26" class="usa-link" aria-describedby="r26">26</a>)</td>
<td rowspan="2" valign="top" align="center" colspan="1">329</td>
<td rowspan="2" valign="top" align="center" colspan="1">Car</td>
<td rowspan="2" valign="top" align="center" colspan="1">I–IV</td>
<td rowspan="2" valign="top" align="center" colspan="1">ChART</td>
<td colspan="3" valign="top" align="center" rowspan="1">NS (R0, I–II)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S (R0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S (R0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td colspan="5" valign="top" align="center" scope="col" rowspan="1">S (R1–2, I–IV)</td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wang <em>et al.</em> (<a href="#r27" class="usa-link" aria-describedby="r27">27</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,850</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">ChART</td>
<td colspan="5" valign="top" align="center" rowspan="1">NS (I–IV)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Liu <em>et al.</em> (<a href="#r28" class="usa-link" aria-describedby="r28">28</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,546</td>
<td valign="top" align="center" rowspan="1" colspan="1">TET</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–III</td>
<td valign="top" align="center" rowspan="1" colspan="1">ChART</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td colspan="2" valign="top" align="center" rowspan="1">NS (II)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">90% <em>vs.</em> 96%</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Rimner <em>et al.</em> (<a href="#r29" class="usa-link" aria-describedby="r29">29</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,263</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">II–III</td>
<td valign="top" align="center" rowspan="1" colspan="1">ITMIG</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td colspan="2" valign="top" align="center" rowspan="1">S (R0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S (R0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">97% <em>vs</em>. 93% (II)<br>92% <em>vs</em>. 76% (III)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Jackson <em>et al.</em> (<a href="#r30" class="usa-link" aria-describedby="r30">30</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4,056</td>
<td valign="top" align="center" rowspan="1" colspan="1">TET</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">NCDB</td>
<td colspan="2" valign="top" align="center" rowspan="1">NS (I–IIA)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S (Thy), NS (Car)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S (Thy), NS (Car)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lim <em>et al.</em> (<a href="#r31" class="usa-link" aria-describedby="r31">31</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">312</td>
<td valign="top" align="center" rowspan="1" colspan="1">Car</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td colspan="3" valign="top" align="center" rowspan="1">NS (I–II)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mou <em>et al.</em> (<a href="#r32" class="usa-link" aria-describedby="r32">32</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2,234</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td colspan="2" valign="top" align="center" rowspan="1">NS (I–IIA)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td colspan="2" valign="top" align="center" rowspan="1">S (III–IV)</td>
<td valign="top" align="center" rowspan="1" colspan="1">75.4% <em>vs.</em> 62.9% (III–IV)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Bian <em>et al.</em> (<a href="#r33" class="usa-link" aria-describedby="r33">33</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,272</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td colspan="3" valign="top" align="center" rowspan="1">S (IIA–III)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gu <em>et al.</em> (<a href="#r34" class="usa-link" aria-describedby="r34">34</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,087</td>
<td valign="top" align="center" rowspan="1" colspan="1">TET</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–II*</td>
<td valign="top" align="center" rowspan="1" colspan="1">ChART</td>
<td colspan="3" valign="top" align="center" rowspan="1">NS (I–II)</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kim <em>et al.</em> (<a href="#r35" class="usa-link" aria-describedby="r35">35</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">632</td>
<td valign="top" align="center" rowspan="1" colspan="1">Car</td>
<td valign="top" align="center" rowspan="1" colspan="1">IIB–III</td>
<td valign="top" align="center" rowspan="1" colspan="1">NCDB</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">S<br>NS (R0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mou <em>et al.</em> (<a href="#r36" class="usa-link" aria-describedby="r36">36</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2,236</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td colspan="2" valign="top" align="center" rowspan="1">NS (I–IIA)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td colspan="2" valign="top" align="center" rowspan="1">S (III–IV)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wu <em>et al.</em> (<a href="#r37" class="usa-link" aria-describedby="r37">37</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">216</td>
<td valign="top" align="center" rowspan="1" colspan="1">Car</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td colspan="5" valign="top" align="center" rowspan="1">NS (I–IV)</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Muslim <em>et al.</em> (<a href="#r38" class="usa-link" aria-describedby="r38">38</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,120</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">IIB–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS<sup>†</sup>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">S<sup>†</sup>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS<sup>†</sup>
</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lococo <em>et al.</em> (<a href="#r39" class="usa-link" aria-describedby="r39">39</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">203</td>
<td valign="top" align="center" rowspan="1" colspan="1">Car</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">ESTS</td>
<td colspan="5" valign="top" align="center" rowspan="1">S</td>
<td valign="top" align="center" rowspan="1" colspan="1">74% <em>vs.</em> 55%</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Zhang <em>et al.</em> (<a href="#r40" class="usa-link" aria-describedby="r40">40</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2,558</td>
<td valign="top" align="center" rowspan="1" colspan="1">TET</td>
<td valign="top" align="center" rowspan="1" colspan="1">I–IV</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td colspan="2" valign="top" align="center" rowspan="1">NS (I–IIA)</td>
<td valign="top" align="center" rowspan="1" colspan="1">S</td>
<td colspan="2" valign="top" align="center" rowspan="1">S (Thy), NS (Car)</td>
<td valign="top" align="center" rowspan="1" colspan="1">82%<em> vs</em>. 75% (IIB, Thy)<br>66% <em>vs</em>. 46% (III–IV, Thy)<br>72% <em>vs</em>. 61% (IIB, Car)<br>38% <em>vs</em>. 23% (III–IV, Car)</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lin <em>et al.</em> (<a href="#r41" class="usa-link" aria-describedby="r41">41</a>)</td>
<td valign="top" align="center" rowspan="1" colspan="1">700</td>
<td valign="top" align="center" rowspan="1" colspan="1">Thy</td>
<td valign="top" align="center" rowspan="1" colspan="1">IIB–III</td>
<td valign="top" align="center" rowspan="1" colspan="1">SEER</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">NS</td>
<td valign="top" align="center" rowspan="1" colspan="1">S</td>
<td valign="top" align="center" rowspan="1" colspan="1">–</td>
<td valign="top" align="center" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p18"><p>*, UICC stage I (equal to Masaoka stages I and II); <sup>†</sup>, disease-specific survival, not OS. OS, overall survival; PORT, postoperative radiotherapy; Car, thymic carcinoma; SEER, Surveillance, Epidemiology, and End Results; NS, not significant; S, significant; Thy, thymoma; BCCAR, British Columbia Cancer Agency Registry; NA, not available; ESTS, European Society of Thoracic Surgeons; TET, thymic epithelial tumor; JART, Japanese Association for Research on the Thymus; ChART, Chinese Alliance for Research of Thymoma database; ITMIG, International Thymic Malignancies Interest Group ; NCDB, National Cancer Database.</p></div></div></section><p>One of the largest retrospective database analyses using the National Cancer Data Base (NCDB) investigated 4,056 patients who underwent surgery for stage I–IV TETs (<a href="#r30" class="usa-link" aria-describedby="r30">30</a>). PORT positively correlated with improved OS in patients diagnosed with either thymoma or thymic carcinoma. For patients with stage IIB or III thymoma, PORT significantly increased OS. Among the subsets with margin-negative stage IIB thymoma, PORT was still associated with better OS. In patients with thymic carcinoma, PORT was significantly correlated with increased OS across the entire cohort. When classified into stages I–IIA, IIB, and III, no significant differences were noted, although a slight increase in OS was observed in patients with stage III disease. In another study using the ITMIG database, Rimner <em>et al.</em> reported an OS benefit with PORT in patients with completely resected stage II and III thymoma (<a href="#r29" class="usa-link" aria-describedby="r29">29</a>).</p>
<p>In contrast, a Surveillance, Epidemiology, and End Results (SEER) database study, which focused on 1,334 patients with thymoma between 1973 and 2005, did not show an OS benefit of PORT in patients with stage IIB disease (<a href="#r18" class="usa-link" aria-describedby="r18">18</a>). Lim <em>et al.</em> used a more recent patient cohort from the same database and reported that PORT in stages III–IV was associated with improved OS; however, no corresponding efficacy was observed in stage IIB (<a href="#r25" class="usa-link" aria-describedby="r25">25</a>). The Japanese Association for Research on the Thymus Database Study, which included 1,265 patients with TETs, showed that PORT improved recurrence-free survival (RFS) for stage II–III thymic carcinoma, but did not improve OS and RFS for stage II–III thymoma (<a href="#r23" class="usa-link" aria-describedby="r23">23</a>).</p>
<p>Five meta-analyses reported PORT for TETs: two TETs, two thymomas, and one thymic carcinoma. Two meta-analyses on PORT for TETs concluded that current evidence did not support any benefit of PORT on recurrence in patients with complete resection of stage II or III TETs (<a href="#r42" class="usa-link" aria-describedby="r42">42</a>,<a href="#r43" class="usa-link" aria-describedby="r43">43</a>). Two meta-analyses, one with 3,823 patients from fourteen studies and the other with 4,746 patients from five studies, showed that increased OS was observed in the subgroup analysis of completely resected stage II or III thymoma (<a href="#r44" class="usa-link" aria-describedby="r44">44</a>,<a href="#r45" class="usa-link" aria-describedby="r45">45</a>). Hamaji <em>et al.</em> also showed that PORT improves the long-term survival outcomes of patients with thymic carcinoma, although stage-specific or resectional status-specific recommendations were not available in the meta-analysis (<a href="#r46" class="usa-link" aria-describedby="r46">46</a>).</p>
<p>These discrepancies among large database studies or meta-analyses can be attributed to the rarity of TETs and the inherent bias in studies, such as patient eligibility, lack of or missing covariates derived from the database, adjuvant radiotherapy, including concurrent use of chemotherapy, or the covariates utilized for propensity score matching analysis. Furthermore, information from Masaoka or Masaoka-Koga staging is not specifically recorded in the NCDB or the SEER database and is inferred and subjectively classified based on recorded information as far as possible. This could be a limitation of large database analysis (<a href="#t4" class="usa-link"><em>Table 4</em></a>).</p>
<section class="tw xbox font-sm" id="t4"><h5 class="obj_head">Table 4. Summary table of advantages and disadvantages of large-database studies.</h5>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="12.48%" span="1">
<col width="43.89%" span="1">
<col width="43.63%" span="1">
<thead><tr>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Database</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pros</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Cons</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">All</td>
<td valign="top" align="left" rowspan="1" colspan="1">Large series of patients</td>
<td valign="top" align="left" rowspan="1" colspan="1">Retrospective studies contain bias; no detailed records of failure patterns, chemotherapy, and radiotherapy</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">SEER</td>
<td valign="top" align="left" rowspan="1" colspan="1">Propensity score-matched studies were performed; cause of death and second malignancy were available; can be focused on specific histological type</td>
<td valign="top" align="left" rowspan="1" colspan="1">Surgical margin status, comorbidities, patient performance status, and Masaoka-Koga staging were unavailable; WHO histology classification was unavailable for the majority; no central review of histological classification was performed; the ethnic characteristics were diverse</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">ChART</td>
<td valign="top" align="left" rowspan="1" colspan="1">Propensity score-matched studies were performed; TNM staging was utilized</td>
<td valign="top" align="left" rowspan="1" colspan="1">Missing patient information caused the majority to excluded from the analysis; Masaoka-Koga staging was unavailable</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">JART</td>
<td valign="top" align="left" rowspan="1" colspan="1">The number of patients with missing data (including OS) was very small; Masaoka staging was utilized</td>
<td valign="top" align="left" rowspan="1" colspan="1">No central review of histological classification was performed</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">ESTS</td>
<td valign="top" align="left" rowspan="1" colspan="1">Clinico-pathological variables affecting long-term survival were investigated; Masaoka staging was utilized; neuroendocrine thymic tumors were excluded from the analysis</td>
<td valign="top" align="left" rowspan="1" colspan="1">Only surgical cases in high-volume centers were included; no central review of histological classification was performed; nodal status and the site of distant metastases were unavailable</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">NCDB</td>
<td valign="top" align="left" rowspan="1" colspan="1">Margin status was incorporated into the analysis</td>
<td valign="top" align="left" rowspan="1" colspan="1">Masaoka-Koga staging was unavailable; no central review of histological classification was performed</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">BCCAR</td>
<td valign="top" align="left" rowspan="1" colspan="1">Variability in clinical behavior and practice variations were focused; Masaoka-Koga staging was utilized; pathology review and reclassification were performed</td>
<td valign="top" align="left" rowspan="1" colspan="1">10% of the data were unavailable for analysis; the number of patients with stage I was limited</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">ITMIG</td>
<td valign="top" align="left" rowspan="1" colspan="1">Completely resected stage II and III thymoma were the focus; Masaoka or Masaoka-Koga staging was utilized</td>
<td valign="top" align="left" rowspan="1" colspan="1">Stages IIA, IIB, and II were all categorized as stage II.</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p23"><p>SEER, Surveillance, Epidemiology, and End Results database; WHO, World Health Organization; ChART, Chinese Alliance for Research of Thymoma database; JART, Japanese Association for Research on the Thymus Database; OS, overall survival; ESTS, European Society of Thoracic Surgeons database; NCDB, National Cancer Database; BCCAR, British Columbia Cancer Agency Registry; ITMIG, International Thymic Malignancies Interest Group Retrospective Database.</p></div></div></section><p>The incompleteness of the traditional Masaoka-Koga staging is also a limitation, as it provides no information on the number of involved organs or tumor size, both of which appear to be promising factors for prognostic stratification (<a href="#r17" class="usa-link" aria-describedby="r17">17</a>,<a href="#r47" class="usa-link" aria-describedby="r47">47</a>). Therefore, an optimal staging system to identify patients with poor prognosis who are at high risk for recurrence is necessary. Such patients could be ideal candidates for PORT or less-invasive surgery combined with PORT. For example, in patients with phrenic nerve involvement (Masaoka-Koga stage III or higher),<em> en bloc </em>resection can lead to diaphragmatic impairment and pulmonary function deterioration. Phrenic nerve-sparing surgery combined with PORT is feasible with an acceptable local control rate of 92.9% (<a href="#r48" class="usa-link" aria-describedby="r48">48</a>). The ninth edition of the TNM stage classification, which is based on a large international database, is expected to contribute significantly to this field.</p></section><section id="sec13"><h4 class="pmc_sec_title">WHO histological subtypes</h4>
<p>The patterns of metastasis and recurrence significantly differ across the WHO classification histological subtypes; the time to metastasis is shortest in thymic carcinoma, followed by high-risk thymoma (WHO types B2 and B3), and longest in low-risk thymoma (A, AB, and B1) (<a href="#r9" class="usa-link" aria-describedby="r9">9</a>,<a href="#r12" class="usa-link" aria-describedby="r12">12</a>,<a href="#r49" class="usa-link" aria-describedby="r49">49</a>,<a href="#r50" class="usa-link" aria-describedby="r50">50</a>). According to an analysis of the ITMIG retrospective database, PORT was associated with a trend toward better OS in all subgroups of stage II and III thymoma, and the greatest and most statistically significant survival advantage with PORT was observed in the subgroup of patients with stage III WHO types B1, B2, or B3 thymoma (<a href="#r29" class="usa-link" aria-describedby="r29">29</a>). In contrast, Muslim <em>et al.</em> reported that SEER database analysis did not reveal a significant disease-specific survival advantage of PORT in any of the WHO histological subtypes among patients with stage IIB–IV thymoma (<a href="#r38" class="usa-link" aria-describedby="r38">38</a>). This could be mainly due to differences in the stages of the eligible patient cohorts. For thymic carcinoma, we did not find any reports examining the differences between squamous cell carcinoma and adenocarcinoma.</p></section><section id="sec14"><h4 class="pmc_sec_title">Resectional status</h4>
<p>Complete resection was associated with improved OS in patients with TETs. Resectional status is a well-known factor for indicating PORT in TETs because PORT is associated with improved OS in patients with incomplete resections or positive margins (<a href="#r28" class="usa-link" aria-describedby="r28">28</a>,<a href="#r30" class="usa-link" aria-describedby="r30">30</a>,<a href="#r35" class="usa-link" aria-describedby="r35">35</a>).</p>
<p>When total resection is not possible, subtotal resection, or debulking surgery, may yield a higher survival rate than that for inoperable thymoma but not for thymic carcinoma (<a href="#r5" class="usa-link" aria-describedby="r5">5</a>). Zhai <em>et al.</em> conducted a retrospective study on debulking surgery plus PORT versus radiotherapy in 47 patients with unresectable stage III thymic carcinoma (<a href="#r51" class="usa-link" aria-describedby="r51">51</a>). The results revealed 5-year OS rates of 54.4% and 0%, respectively. Thus, there may be merit in the so-called “debulking procedures” followed by PORT, but only in highly selected cases. Mastromarino <em>et al.</em> investigated 79 patients with types B2 and B3 thymomas, including R1 or R2 residual tumors (<a href="#r52" class="usa-link" aria-describedby="r52">52</a>). Regardless of whether residual tumors existed in the primary tumor or pleural space, PORT significantly improved progression-free survival in patients with R1 residual tumors, whereas postoperative chemotherapy or chemoradiotherapy improved cancer-specific survival in patients with R2 residual tumors.</p>
<p>In summary, the current literature suggests that PORT does not improve OS in stage I–IIA TETs, with inconsistent results for stage IIB–III TETs. The currently available data suggest that stage II–III TETs are a heterogeneous population; at least stages IIA and IIB need to be considered separately as indications for PORT, not considered together as stage II. PORT for stage III TETs can contribute to improved OS in patients with higher-risk grades, such as carcinoma or WHO type B2–B3, and may benefit from PORT in terms of improved OS when they do not develop distant metastasis. Identifying patients less likely to develop early distant metastases and can genuinely benefit from PORT remains a gray zone that requires further exploration.</p></section></section><section id="sec15"><h3 class="pmc_sec_title">Recurrent TET</h3>
<p>After definitive radiotherapy or PORT, the 5-year cumulative incidence of all intrathoracic failures was 24% (<a href="#r53" class="usa-link" aria-describedby="r53">53</a>). The most common site of failure was the out-of-field pleural space, followed by the 5-year incidence of in-field failure of 7%. Although radiotherapy is critical in the multimodal treatment of intrathoracic recurrent TETs (<a href="#r54" class="usa-link" aria-describedby="r54">54</a>,<a href="#r55" class="usa-link" aria-describedby="r55">55</a>), several aspects warrant careful consideration.</p>
<p>First, the prognostic significance of PORT in patients with recurrent TETs remains unclear. Several studies with a limited sample size have indicated that adjuvant therapies, including PORT, do not effectively reduce recurrence or improve survival outcomes (<a href="#r56" class="usa-link" aria-describedby="r56">56</a>,<a href="#r57" class="usa-link" aria-describedby="r57">57</a>). Second, when considering PORT for recurrent TETs, examining the overlap between the field irradiated during initial PORT and the target volume at the time of recurrence is imperative. Furthermore, it is essential to ensure that the cumulative dose to the organs at risk is within the established dose constraints, as described in “Radiotherapy techniques”. Recently, phase II trials have demonstrated that targeted therapies, including everolimus, lenvatinib, and sunitinib, may induce durable disease control in patients with recurrent TETs as second-line treatment (<a href="#r58" class="usa-link" aria-describedby="r58">58</a>-<a href="#r60" class="usa-link" aria-describedby="r60">60</a>). However, there is no evidence supporting the concurrent use of systemic therapies and radiotherapy. Therefore, when administering PORT for recurrent TETs, pausing targeted therapy before and after PORT based on its half-life should be considered.</p></section></section><section id="sec16"><h2 class="pmc_sec_title">Radiotherapy techniques</h2>
<section id="sec17"><h3 class="pmc_sec_title">Photon beam radiotherapy</h3>
<p>Photon beam radiotherapy is commonly used in PORT. In this section, we outline the standard procedures and techniques for photon beam radiotherapy based on previous literature and guidelines (<a href="#r13" class="usa-link" aria-describedby="r13">13</a>,<a href="#r61" class="usa-link" aria-describedby="r61">61</a>,<a href="#r62" class="usa-link" aria-describedby="r62">62</a>). Three-dimensional conformal radiotherapy (3D-CRT) is conventionally used as a common delivery technique. Recently, intensity-modulated radiotherapy (IMRT), which enables the delivery of conformal radiation doses to irregularly shaped target volumes with high-precision fitted dose distribution, could be expected to decrease the dose delivered to organs at risk, sparing over 3D-CRT and has been applied to PORT (<a href="#r63" class="usa-link" aria-describedby="r63">63</a>).</p>
<p>Before initiating PORT, physicians should ensure the absence of infection or wound dehiscence. While there is no definitive maximum period from surgery to PORT, it has been reported that a delay of more than 3 months post-surgery often leads physicians to decide to skip PORT (<a href="#r14" class="usa-link" aria-describedby="r14">14</a>). Given that the respiratory motion of the upper mediastinum is typically minimal, respiratory-gated radiotherapy or breath-hold radiotherapy techniques to reduce motion are not mandatory.</p>
<p>Postoperative changes should be considered when delineating target volumes. As expert agreement for delineating postoperative cases is low compared with that of definitive cases, a contouring atlas for TETs with expert consensus is urgently needed (<a href="#r64" class="usa-link" aria-describedby="r64">64</a>). The utilization of four-dimensional-CT and positron emission tomography-CT fusion should be implemented for contour delineation, if available (<a href="#r64" class="usa-link" aria-describedby="r64">64</a>). It is also recommended to fuse preoperative CT with treatment-planning CT and deform preoperative CT to fit the treatment-planning CT. Gross tumor volume was defined as incomplete resection. In cases of complete resection, the clinical target volume (CTV) should encompass the tumor bed, surgical clips, and potential sites of residual disease. In cases of incomplete resection, the entire thymus should be included in the CTV. In instances where the margins are close or positive, surgical clips are useful for identifying the site of boost irradiation. The rates of lymphogenous metastasis in thymoma and thymic carcinoma are 1.8 and 27%, respectively (<a href="#r65" class="usa-link" aria-describedby="r65">65</a>). There was no significant difference in 5-year OS between local radiation therapy (targeting the tumor bed and anterior mediastinal areas only) and elective nodal irradiation (targeting the entire mediastinal and supraclavicular regions) in patients with TETs (<a href="#r65" class="usa-link" aria-describedby="r65">65</a>,<a href="#r66" class="usa-link" aria-describedby="r66">66</a>). Therefore, elective nodal irradiation is not recommended for TETs. The prescribed doses range from 45–50 Gy for negative or close margins, 54 Gy for microscopically positive resection margins, and 60–70 Gy for gross residual disease, administered in 1.8–2.0 Gy fractions.</p>
<p>As the dose constraints of organs at risk, normal tissue dose-volume constraints for conventionally fractionated radiotherapy for lung cancer could be applied to PORT in TETs; spinal cord max dose ≤50 Gy; lung V<sub>20Gy</sub> ≤35–40% (V<sub>xGy</sub>: percentage of the volume receiving at least X Gy), mean dose ≤20 Gy; heart V<sub>50Gy</sub> ≤25%, mean dose ≤20 Gy; esophagus mean dose ≤34 Gy, V<sub>60Gy</sub> ≤17% (<a href="#r67" class="usa-link" aria-describedby="r67">67</a>).</p></section><section id="sec18"><h3 class="pmc_sec_title">Proton beam therapy</h3>
<p>A dosimetric comparison study has shown that both proton beam radiotherapy and carbon-ion radiotherapy excel in sparing organs at risk, such as the heart, lungs, left ventricle, esophagus, and spinal cord, and in improving target volume coverage when compared to photon IMRT (<a href="#r63" class="usa-link" aria-describedby="r63">63</a>,<a href="#r68" class="usa-link" aria-describedby="r68">68</a>-<a href="#r72" class="usa-link" aria-describedby="r72">72</a>). This is anticipated to reduce toxicity, potentially decreasing major cardiac events and the occurrence of secondary malignant neoplasms. Previous studies on proton beam radiotherapy for TETs are presented in <a href="#t5" class="usa-link"><em>Table 5</em></a>. No toxicities more severe than grade 3 were observed following proton beam radiotherapy, and the OS and locoregional control rates were comparable with those achieved with photon beam radiotherapy. It should be noted that the sample sizes in these studies were small and included both PORT and definitive RT. Future clinical trials with larger cohorts and direct comparisons between proton and photon beam radiotherapies are essential.</p>
<section class="tw xbox font-sm" id="t5"><h4 class="obj_head">Table 5. Literature on proton beam radiotherapy in TETs for PORT.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col width="11.13%" span="1">
<col width="7.97%" span="1">
<col width="14.51%" span="1">
<col width="11.16%" span="1">
<col width="17.86%" span="1">
<col width="25.68%" span="1">
<col width="11.69%" span="1">
<thead><tr>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Authors</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Year</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">N [N of PORT]</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Primary</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Prescribed dose, median (range)</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Efficacy</th>
<th valign="middle" align="left" scope="col" rowspan="1" colspan="1">Toxicity ≥ grade 3</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="2" valign="top" align="left" scope="row" colspan="1">Vogel <em>et al.</em> (<a href="#r73" class="usa-link" aria-describedby="r73">73</a>)</td>
<td rowspan="2" valign="top" align="left" colspan="1">2016</td>
<td rowspan="2" valign="top" align="left" colspan="1">27 [17]</td>
<td rowspan="2" valign="top" align="left" colspan="1">TET</td>
<td rowspan="2" valign="top" align="left" colspan="1">61.2 CGE (50.4–70.0 CGE)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3-year OS: 94%</td>
<td rowspan="2" valign="top" align="left" colspan="1">No</td>
</tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">3-year regional control: 96%</td></tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Parikh <em>et al.</em> (<a href="#r71" class="usa-link" aria-describedby="r71">71</a>)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2016</td>
<td valign="top" align="left" rowspan="1" colspan="1">4 [4]</td>
<td valign="top" align="left" rowspan="1" colspan="1">Thymoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">57.0 CGE (50.4–66.6 CGE)</td>
<td valign="top" align="left" rowspan="1" colspan="1">No death and no recurrences occurred</td>
<td valign="top" align="left" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td valign="top" align="left" scope="row" rowspan="1" colspan="1">Zhu <em>et al.</em> (<a href="#r70" class="usa-link" aria-describedby="r70">70</a>)</td>
<td valign="top" align="left" rowspan="1" colspan="1">2018</td>
<td valign="top" align="left" rowspan="1" colspan="1">6 [5]</td>
<td valign="top" align="left" rowspan="1" colspan="1">Thymoma</td>
<td valign="top" align="left" rowspan="1" colspan="1">60 GyE (54–70 GyE)</td>
<td valign="top" align="left" rowspan="1" colspan="1">3 patients experienced recurrences (0 local recurrence)</td>
<td valign="top" align="left" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td rowspan="2" valign="top" align="left" scope="row" colspan="1">Mercado <em>et al.</em> (<a href="#r74" class="usa-link" aria-describedby="r74">74</a>)</td>
<td rowspan="2" valign="top" align="left" colspan="1">2019</td>
<td rowspan="2" valign="top" align="left" colspan="1">30 [26]</td>
<td rowspan="2" valign="top" align="left" colspan="1">TET</td>
<td rowspan="2" valign="top" align="left" colspan="1">54 GyE (45–70 GyE)</td>
<td valign="top" align="left" rowspan="1" colspan="1">5 patients experienced recurrence (1 local recurrence)</td>
<td rowspan="2" valign="top" align="left" colspan="1">No</td>
</tr>
<tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">4 died (3 died of TETs)</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p36"><p>TET, thymic epithelial tumor; PORT, postoperative radiotherapy; CGE, cobalt-gray equivalent; OS, overall survival; GyE, gray equivalent.</p></div></div></section></section></section><section id="sec19"><h2 class="pmc_sec_title">Toxicity</h2>
<p>Common acute toxicities associated with PORT for TETs include fatigue, dermatitis, esophagitis, pneumonitis, and myelosuppression. Given the location of the anterior mediastinum, the severity of esophagitis is typically milder than in other intrathoracic tumors such as esophageal or lung cancers. Consequently, this study focused on detailing the more significant late toxicities that require special consideration, including pneumonitis, cardiotoxicities, and secondary malignancies.</p>
<section id="sec20"><h3 class="pmc_sec_title">Radiation pneumonitis</h3>
<p>Previous studies have reported that the irradiated dose to the normal lung is one of the common risk factors for developing radiation pneumonitis in patients with lung cancer: lung V<sub>20Gy</sub>, mean lung dose, and absolute lung volume spared from a 5 Gy dose (<a href="#r75" class="usa-link" aria-describedby="r75">75</a>,<a href="#r76" class="usa-link" aria-describedby="r76">76</a>). In PORT for TETs, the irradiated dose to the normal lung is usually lower than that in definitive radiotherapy for lung cancer because the tumor bed is located in the mediastinum. The incidence of grade 2 or higher radiation pneumonitis in PORT for TETs is reported to be &lt;10%, which is lower than that in definitive radiotherapy for lung cancer. Therefore, only a few studies have reported the risk factors for radiation pneumonitis in TETs. Moiseenko <em>et al.</em> quantified the influence of irradiated lung volume and dose on the lung response and showed that the mean lung dose was strongly correlated with lung complications, including pneumonitis and fibrosis (<a href="#r77" class="usa-link" aria-describedby="r77">77</a>). Tomita <em>et al.</em> reported that pulmonary artery V<sub>35Gy</sub> was significantly associated with radiation pneumonitis in patients with TET (<a href="#r78" class="usa-link" aria-describedby="r78">78</a>). In summary, efforts should be made to reduce the irradiation dose to the normal lung as much as possible during PORT for TETs, even though the risk of radiation pneumonitis is very low.</p></section><section id="sec21"><h3 class="pmc_sec_title">Radiation-induced cardiotoxicities</h3>
<p>The onset of radiation-induced cardiotoxicities occurs years or decades after PORT, and the typical symptoms are acute pericarditis, pericardial effusion, coronary artery disease, stenosis and regurgitation of valves, arrhythmia, and heart failure. Radiation-induced cardiotoxicities are a concern in long-term survivors of thoracic irradiation, such as patients with breast cancer or lymphoma. It is well known that after PORT in patients with breast cancer, the rates of major coronary events increase linearly with the mean dose to the heart by 7.4% per gray (<a href="#r79" class="usa-link" aria-describedby="r79">79</a>). Meanwhile, a SEER database analysis showed that radiotherapy does not increase the risk of cardiac mortality (12-year cumulative incidence or death, 10.2% radiation <em>vs.</em> 7.5% no radiation) in patients with thymoma (<a href="#r18" class="usa-link" aria-describedby="r18">18</a>). Given the prolonged survival of patients undergoing TETs, cardiotoxicity remains a critical concern following mediastinal irradiation via PORT. There is a pressing need for prospective studies that screen for cardiac event risks and consistently monitor radiation-induced cardiotoxicity.</p></section><section id="sec22"><h3 class="pmc_sec_title">Second malignancies</h3>
<p>Thymomas are associated with an increased risk of secondary malignancies. Patients face a higher risk of death from this second type of cancer than from recurrence (<a href="#r80" class="usa-link" aria-describedby="r80">80</a>). The lifetime attributable risk of secondary fatal cancer in patients receiving PORT (50 Gy in 25 fractions) for thymoma has been reported to be approximately 1–3% (<a href="#r81" class="usa-link" aria-describedby="r81">81</a>). Mou <em>et al.</em> reported that patients with thymoma who underwent surgery with PORT had a higher rate of secondary cancers than those who underwent surgery without PORT, based on the SEER database (<a href="#r32" class="usa-link" aria-describedby="r32">32</a>). In contrast, two studies concluded that radiotherapy did not increase the risk of secondary malignancy in patients with thymoma (<a href="#r18" class="usa-link" aria-describedby="r18">18</a>,<a href="#r82" class="usa-link" aria-describedby="r82">82</a>).</p>
<p>The incidence of secondary malignancies and deaths from secondary malignancies are lower in thymic carcinoma than in thymoma (<a href="#r83" class="usa-link" aria-describedby="r83">83</a>).</p>
<p>The association between TETs and secondary malignancies cannot be attributed solely to radiotherapy. Further investigations with long-term follow-ups and large sample sizes are needed because of the rare incidence of TETs and secondary malignancies.</p></section></section><section id="sec23"><h2 class="pmc_sec_title">Future indications</h2>
<p>Radiotherapy has undergone significant advancements in recent decades. Research supporting the use of IMRT or particle therapy is ongoing, and accumulated data are expected to be published in the near future, contributing to the establishment of new evidence. Adopting these innovative radiotherapy techniques for TETs is expected to enhance patient outcomes (<a href="#r84" class="usa-link" aria-describedby="r84">84</a>). For definitive treatment or PORT, we have highlighted the radiotherapy techniques projected to be utilized for TETs in the coming years.</p>
<p>RADIORHYTHMIC, a phase III randomized study of PORT in stage IIB/III thymomas after complete surgical resection, was conducted by the RYTHMIC and is currently ongoing (<a href="#r85" class="usa-link" aria-describedby="r85">85</a>). Three hundred and fourteen patients will be randomized to either the PORT group (50–54 Gy to the mediastinum using IMRT or proton beam therapy) or the surveillance group. The results will be expected in 2028. Hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma has been developed as part of a multimodality treatment for patients receiving pleurectomy/decortication to spare the affected side of the lung (<a href="#r86" class="usa-link" aria-describedby="r86">86</a>). As recurrent TETs often develop pleural dissemination, IMPRINT can be applied to control pleural dissemination (<a href="#r53" class="usa-link" aria-describedby="r53">53</a>,<a href="#r87" class="usa-link" aria-describedby="r87">87</a>). SABR-COMET, a randomized phase II study aimed at determining the effect of stereotactic body radiotherapy (SBRT) in patients with a controlled primary tumor and 1–5 oligometastatic lesions, demonstrated that SBRT was associated with improved OS (<a href="#r88" class="usa-link" aria-describedby="r88">88</a>). Yano <em>et al.</em> reported 24 patients with recurrent thymoma, revealing that patients with a limited number of recurrent lesions had a better prognosis regardless of treatment (<a href="#r89" class="usa-link" aria-describedby="r89">89</a>). Based on these findings, SBRT may be an effective treatment option for patients with oligometastatic TETs. Adaptive radiotherapy, which aims to decrease the dose to normal tissues and allow for dose escalation to the target volume by changing the radiation treatment plan delivered to a patient during the course of radiotherapy to account for either temporal changes in anatomy (e.g., tumor size, internal motion, variations in respiratory patterns, weight loss) or changes in tumor biology/function (e.g., hypoxia) (<a href="#r90" class="usa-link" aria-describedby="r90">90</a>), is promising for application in TETs (<a href="#r91" class="usa-link" aria-describedby="r91">91</a>,<a href="#r92" class="usa-link" aria-describedby="r92">92</a>). Intraoperative radiotherapy has been used for intractable cancers such as pancreatic cancer and osteosarcoma (<a href="#r93" class="usa-link" aria-describedby="r93">93</a>,<a href="#r94" class="usa-link" aria-describedby="r94">94</a>). Cui <em>et al.</em> applied intraoperative radiotherapy (8–10 Gy) to TETs and reported its safety and efficacy in 14 patients with invasive thymomas as a less time-consuming and less invasive radiotherapy technique for improving locoregional control (<a href="#r95" class="usa-link" aria-describedby="r95">95</a>). The mean time for installation and operation of the radiation equipment 57.6 minutes (range, 48–72 minutes). During a median follow-up period of 41 months, no recurrence, death, or severe toxicity were observed.</p>
<p>As part of the multimodal treatment, surgical approaches, systemic therapy, and radiotherapy techniques are drastically evolving. Salfity <em>et al.</em> reported on minimally invasive surgery in managing resectable thymomas based on the NCDB and showed that PORT was less frequent in thoracoscopic thymectomies than in traditional open sternotomy (<a href="#r96" class="usa-link" aria-describedby="r96">96</a>). As the efficacy of PORT in different surgical approaches remains unknown, future investigations may reveal the different indications and irradiation fields for PORT depending on the surgical approach. Several studies have reported abscopal and bystander effects after radiotherapy in thymic carcinoma (<a href="#r97" class="usa-link" aria-describedby="r97">97</a>,<a href="#r98" class="usa-link" aria-describedby="r98">98</a>). A combination of immunotherapy and radiotherapy is expected to enhance these effects and improve patient outcomes. The abscopal effect was proposed in 1953, and it is hypothesized that the immune system plays a role in mediating this phenomenon, leading to therapeutic effects on lesions located outside the irradiated field (<a href="#r99" class="usa-link" aria-describedby="r99">99</a>,<a href="#r100" class="usa-link" aria-describedby="r100">100</a>). Currently, a clinical investigation on the abscopal effect of radiotherapy in combination with recombinant human granulocyte-macrophage colony-stimulating factor for advanced TETs is ongoing in China (ClinicalTrials.gov; <a href="https://clinicaltrials.gov/ct2/show/NCT05407649" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05407649</a>).</p>
<p>Advancements in radiotherapy techniques combined with other novel surgical or systematic approaches can further improve the outcomes. Therefore, an optimal treatment strategy combined with PORT should be identified using prospective data.</p></section><section id="sec24"><h2 class="pmc_sec_title">Conclusions</h2>
<p>This narrative review presents a synthesis of the existing literature on the efficacy and toxicities of PORT in relation to OS. Considering the Masaoka-Koga staging, WHO histological subtypes, and resection status, indications for PORT have been determined for stage IIB–III TETs, although inconsistent results have been observed. Identifying patients who benefit from PORT for locoregional control can refine treatment strategies for TETs. Given that TETs typically result in long-term survival, late toxicities, such as radiation pneumonitis, radiation-induced cardiac toxicities, and secondary malignancies, are significant. However, a decrease in these toxicities has been anticipated with the introduction of advanced radiotherapy techniques. Further studies are required to evaluate the value of PORT based on patient characteristics and combination therapy.</p></section><section id="sec25"><h2 class="pmc_sec_title">Supplementary</h2>
<section class="sm xbox font-sm" id="supplementary-material1"><div class="caption p"><p>The article’s supplementary files as</p></div></section><section class="sm xbox font-sm" id="su1"><div class="media p" id="d67e1612">
<div class="caption">
<a href="/articles/instance/11330913/bin/med-08-40-rc.pdf" data-ga-action="click_feat_suppl" class="usa-link">med-08-40-rc.pdf</a><sup> (97.9KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/med-23-38</div>
</div>
<div class="media p" id="d67e1615">
<div class="caption">
<a href="/articles/instance/11330913/bin/med-08-40-coif.pdf" data-ga-action="click_feat_suppl" class="usa-link">med-08-40-coif.pdf</a><sup> (116.6KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/med-23-38</div>
</div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p><em>Funding:</em> This work was supported by the JSPS KAKENHI (No. JP22K20856).</p></section><section id="notes1"><p><em>Ethical Statement:</em> The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p><em>Provenance and Peer Review:</em> This article was commissioned by the Guest Editor (Masatsugu Hamaji) for the series “Locally Advanced Thymic Epithelial Tumors” published in <em>Mediastinum</em>. The article has undergone external peer review.</p></div>
<div class="fn p" id="fn2"><p><em>Reporting Checklist:</em> The authors have completed the Narrative Review reporting checklist. Available at <a href="https://med.amegroups.com/article/view/10.21037/med-23-38/rc" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://med.amegroups.com/article/view/10.21037/med-23-38/rc</a></p></div>
<div class="fn p" id="fn4"><p><em>Conflicts of Interest:</em> Both authors have completed the ICMJE uniform disclosure form (available at <a href="https://med.amegroups.com/article/view/10.21037/med-23-38/coif" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://med.amegroups.com/article/view/10.21037/med-23-38/coif</a>). The series “Locally Advanced Thymic Epithelial Tumors” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.</p></div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="r1">
<span class="label">1.</span><cite>Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.
Int J Cancer
2003;105:546-51. 10.1002/ijc.11099
</cite> [<a href="https://doi.org/10.1002/ijc.11099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12712448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=Malignant%20thymoma%20in%20the%20United%20States:%20demographic%20patterns%20in%20incidence%20and%20associations%20with%20subsequent%20malignancies.&amp;author=EA%20Engels&amp;author=RM%20Pfeiffer&amp;volume=105&amp;publication_year=2003&amp;pages=546-51&amp;pmid=12712448&amp;doi=10.1002/ijc.11099&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r2">
<span class="label">2.</span><cite>de Jong WK, Blaauwgeers JL, Schaapveld M, et al.
Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy.
Eur J Cancer
2008;44:123-30. 10.1016/j.ejca.2007.11.004
</cite> [<a href="https://doi.org/10.1016/j.ejca.2007.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18068351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cancer&amp;title=Thymic%20epithelial%20tumours:%20a%20population-based%20study%20of%20the%20incidence,%20diagnostic%20procedures%20and%20therapy.&amp;author=WK%20de%20Jong&amp;author=JL%20Blaauwgeers&amp;author=M%20Schaapveld&amp;volume=44&amp;publication_year=2008&amp;pages=123-30&amp;pmid=18068351&amp;doi=10.1016/j.ejca.2007.11.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r3">
<span class="label">3.</span><cite>Zhao Y, Shi J, Fan L, et al.
Surgical treatment of thymoma: an 11-year experience with 761 patients.
Eur J Cardiothorac Surg
2016;49:1144-9. 10.1093/ejcts/ezv288
</cite> [<a href="https://doi.org/10.1093/ejcts/ezv288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26324679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cardiothorac%20Surg&amp;title=Surgical%20treatment%20of%20thymoma:%20an%2011-year%20experience%20with%20761%20patients.&amp;author=Y%20Zhao&amp;author=J%20Shi&amp;author=L%20Fan&amp;volume=49&amp;publication_year=2016&amp;pages=1144-9&amp;pmid=26324679&amp;doi=10.1093/ejcts/ezv288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r4">
<span class="label">4.</span><cite>Litvak AM, Woo K, Hayes S, et al.
Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging.
J Thorac Oncol
2014;9:1810-5. 10.1097/JTO.0000000000000363
</cite> [<a href="https://doi.org/10.1097/JTO.0000000000000363" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4663074/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25393794/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Clinical%20characteristics%20and%20outcomes%20for%20patients%20with%20thymic%20carcinoma:%20evaluation%20of%20Masaoka%20staging.&amp;author=AM%20Litvak&amp;author=K%20Woo&amp;author=S%20Hayes&amp;volume=9&amp;publication_year=2014&amp;pages=1810-5&amp;pmid=25393794&amp;doi=10.1097/JTO.0000000000000363&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r5">
<span class="label">5.</span><cite>Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.
Ann Thorac Surg
2003;76:878-84; discussion 884-5. 10.1016/S0003-4975(03)00555-1
</cite> [<a href="https://doi.org/10.1016/S0003-4975(03)00555-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12963221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=Therapy%20for%20thymic%20epithelial%20tumors:%20a%20clinical%20study%20of%201,320%20patients%20from%20Japan.&amp;author=K%20Kondo&amp;author=Y%20Monden&amp;volume=76&amp;publication_year=2003&amp;pages=878-84&amp;pmid=12963221&amp;doi=10.1016/S0003-4975(03)00555-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r6">
<span class="label">6.</span><cite>Eng TY, Fuller CD, Jagirdar J, et al.
Thymic carcinoma: state of the art review.
Int J Radiat Oncol Biol Phys
2004;59:654-64. 10.1016/j.ijrobp.2003.11.021
</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2003.11.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15183468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Thymic%20carcinoma:%20state%20of%20the%20art%20review.&amp;author=TY%20Eng&amp;author=CD%20Fuller&amp;author=J%20Jagirdar&amp;volume=59&amp;publication_year=2004&amp;pages=654-64&amp;pmid=15183468&amp;doi=10.1016/j.ijrobp.2003.11.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r7">
<span class="label">7.</span><cite>Koga K, Matsuno Y, Noguchi M, et al.
A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma.
Pathol Int
1994;44:359-67. 10.1111/j.1440-1827.1994.tb02936.x
</cite> [<a href="https://doi.org/10.1111/j.1440-1827.1994.tb02936.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8044305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathol%20Int&amp;title=A%20review%20of%2079%20thymomas:%20modification%20of%20staging%20system%20and%20reappraisal%20of%20conventional%20division%20into%20invasive%20and%20non-invasive%20thymoma.&amp;author=K%20Koga&amp;author=Y%20Matsuno&amp;author=M%20Noguchi&amp;volume=44&amp;publication_year=1994&amp;pages=359-67&amp;pmid=8044305&amp;doi=10.1111/j.1440-1827.1994.tb02936.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r8">
<span class="label">8.</span><cite>Detterbeck FC, Nicholson AG, Kondo K, et al.
The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms.
J Thorac Oncol
2011;6:S1710-6. 10.1097/JTO.0b013e31821e8cff
</cite> [<a href="https://doi.org/10.1097/JTO.0b013e31821e8cff" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21847052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=The%20Masaoka-Koga%20stage%20classification%20for%20thymic%20malignancies:%20clarification%20and%20definition%20of%20terms.&amp;author=FC%20Detterbeck&amp;author=AG%20Nicholson&amp;author=K%20Kondo&amp;volume=6&amp;publication_year=2011&amp;pages=S1710-6&amp;pmid=21847052&amp;doi=10.1097/JTO.0b013e31821e8cff&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r9">
<span class="label">9.</span><cite>Marx A, Chan JKC, Chalabreysse L, et al.
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
J Thorac Oncol
2022;17:200-13. 10.1016/j.jtho.2021.10.010
</cite> [<a href="https://doi.org/10.1016/j.jtho.2021.10.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34695605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=The%202021%20WHO%20Classification%20of%20Tumors%20of%20the%20Thymus%20and%20Mediastinum:%20What%20Is%20New%20in%20Thymic%20Epithelial,%20Germ%20Cell,%20and%20Mesenchymal%20Tumors?&amp;author=A%20Marx&amp;author=JKC%20Chan&amp;author=L%20Chalabreysse&amp;volume=17&amp;publication_year=2022&amp;pages=200-13&amp;pmid=34695605&amp;doi=10.1016/j.jtho.2021.10.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r10">
<span class="label">10.</span><cite>Girard N, Mornex F, Van Houtte P, et al.
Thymoma: a focus on current therapeutic management.
J Thorac Oncol
2009;4:119-26. 10.1097/JTO.0b013e31818e105c
</cite> [<a href="https://doi.org/10.1097/JTO.0b013e31818e105c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19096319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Thymoma:%20a%20focus%20on%20current%20therapeutic%20management.&amp;author=N%20Girard&amp;author=F%20Mornex&amp;author=P%20Van%20Houtte&amp;volume=4&amp;publication_year=2009&amp;pages=119-26&amp;pmid=19096319&amp;doi=10.1097/JTO.0b013e31818e105c&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r11">
<span class="label">11.</span><cite>Gao L, Wang C, Fang W, et al.
Outcome of multimodality treatment for 188 cases of type B3 thymoma.
J Thorac Oncol
2013;8:1329-34. 10.1097/JTO.0b013e31829ceb50
</cite> [<a href="https://doi.org/10.1097/JTO.0b013e31829ceb50" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24457243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Outcome%20of%20multimodality%20treatment%20for%20188%20cases%20of%20type%20B3%20thymoma.&amp;author=L%20Gao&amp;author=C%20Wang&amp;author=W%20Fang&amp;volume=8&amp;publication_year=2013&amp;pages=1329-34&amp;pmid=24457243&amp;doi=10.1097/JTO.0b013e31829ceb50&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r12">
<span class="label">12.</span><cite>Weis CA, Yao X, Deng Y, et al.
The impact of thymoma histotype on prognosis in a worldwide database.
J Thorac Oncol
2015;10:367-72. 10.1097/JTO.0000000000000393
</cite> [<a href="https://doi.org/10.1097/JTO.0000000000000393" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4318643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25616178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=The%20impact%20of%20thymoma%20histotype%20on%20prognosis%20in%20a%20worldwide%20database.&amp;author=CA%20Weis&amp;author=X%20Yao&amp;author=Y%20Deng&amp;volume=10&amp;publication_year=2015&amp;pages=367-72&amp;pmid=25616178&amp;doi=10.1097/JTO.0000000000000393&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r13">
<span class="label">13.</span><cite>National Comprehensive Cancer Network. Thymomas and Thymic Carcinomas (Version 1.2023); (cited 2023 Aug 3). Available online: <a href="https://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf</a></cite>
</li>
<li id="r14">
<span class="label">14.</span><cite>Basse C, Thureau S, Bota S, et al.
Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort.
J Thorac Oncol
2017;12:1715-22. 10.1016/j.jtho.2017.07.023
</cite> [<a href="https://doi.org/10.1016/j.jtho.2017.07.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28774861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Multidisciplinary%20Tumor%20Board%20Decision%20Making%20for%20Postoperative%20Radiotherapy%20in%20Thymic%20Epithelial%20Tumors:%20Insights%20from%20the%20RYTHMIC%20Prospective%20Cohort.&amp;author=C%20Basse&amp;author=S%20Thureau&amp;author=S%20Bota&amp;volume=12&amp;publication_year=2017&amp;pages=1715-22&amp;pmid=28774861&amp;doi=10.1016/j.jtho.2017.07.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r15">
<span class="label">15.</span><cite>Ahmad U. The eighth edition TNM stage classification for thymic tumors: What do I need to know? J Thorac Cardiovasc Surg 2021;161:1524-9.</cite> [<a href="https://doi.org/10.1016/j.jtcvs.2020.10.131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33468329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ahmad%20U.%20The%20eighth%20edition%20TNM%20stage%20classification%20for%20thymic%20tumors:%20What%20do%20I%20need%20to%20know?%20J%20Thorac%20Cardiovasc%20Surg%202021;161:1524-9." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r16">
<span class="label">16.</span><cite>Liang G, Gu Z, Li Y, et al.
Comparison of the Masaoka-Koga staging and the International Association for the Study of Lung Cancer/the International Thymic Malignancies Interest Group proposal for the TNM staging systems based on the Chinese Alliance for Research in Thymomas retrospective database.
J Thorac Dis
2016;8:727-37. 10.21037/jtd.2016.03.22
</cite> [<a href="https://doi.org/10.21037/jtd.2016.03.22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4824721/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27114841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Dis&amp;title=Comparison%20of%20the%20Masaoka-Koga%20staging%20and%20the%20International%20Association%20for%20the%20Study%20of%20Lung%20Cancer/the%20International%20Thymic%20Malignancies%20Interest%20Group%20proposal%20for%20the%20TNM%20staging%20systems%20based%20on%20the%20Chinese%20Alliance%20for%20Research%20in%20Thymomas%20retrospective%20database.&amp;author=G%20Liang&amp;author=Z%20Gu&amp;author=Y%20Li&amp;volume=8&amp;publication_year=2016&amp;pages=727-37&amp;pmid=27114841&amp;doi=10.21037/jtd.2016.03.22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r17">
<span class="label">17.</span><cite>Chiappetta M, Lococo F, Pogliani L, et al.
Masaoka-Koga and TNM Staging System in Thymic Epithelial Tumors: Prognostic Comparison and the Role of the Number of Involved Structures.
Cancers (Basel)
2021;13:5254. 10.3390/cancers13215254
</cite> [<a href="https://doi.org/10.3390/cancers13215254" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8582470/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34771417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Masaoka-Koga%20and%20TNM%20Staging%20System%20in%20Thymic%20Epithelial%20Tumors:%20Prognostic%20Comparison%20and%20the%20Role%20of%20the%20Number%20of%20Involved%20Structures.&amp;author=M%20Chiappetta&amp;author=F%20Lococo&amp;author=L%20Pogliani&amp;volume=13&amp;publication_year=2021&amp;pages=5254&amp;pmid=34771417&amp;doi=10.3390/cancers13215254&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r18">
<span class="label">18.</span><cite>Fernandes AT, Shinohara ET, Guo M, et al.
The role of radiation therapy in malignant thymoma: a Surveillance, Epidemiology, and End Results database analysis.
J Thorac Oncol
2010;5:1454-60. 10.1097/JTO.0b013e3181e8f345
</cite> [<a href="https://doi.org/10.1097/JTO.0b013e3181e8f345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20651611/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=The%20role%20of%20radiation%20therapy%20in%20malignant%20thymoma:%20a%20Surveillance,%20Epidemiology,%20and%20End%20Results%20database%20analysis.&amp;author=AT%20Fernandes&amp;author=ET%20Shinohara&amp;author=M%20Guo&amp;volume=5&amp;publication_year=2010&amp;pages=1454-60&amp;pmid=20651611&amp;doi=10.1097/JTO.0b013e3181e8f345&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r19">
<span class="label">19.</span><cite>Patel S, Macdonald OK, Nagda S, et al.
Evaluation of the role of radiation therapy in the management of malignant thymoma.
Int J Radiat Oncol Biol Phys
2012;82:1797-801. 10.1016/j.ijrobp.2011.03.010
</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2011.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21596484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Evaluation%20of%20the%20role%20of%20radiation%20therapy%20in%20the%20management%20of%20malignant%20thymoma.&amp;author=S%20Patel&amp;author=OK%20Macdonald&amp;author=S%20Nagda&amp;volume=82&amp;publication_year=2012&amp;pages=1797-801&amp;pmid=21596484&amp;doi=10.1016/j.ijrobp.2011.03.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r20">
<span class="label">20.</span><cite>Weksler B, Shende M, Nason KS, et al.
The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study.
Ann Thorac Surg
2012;93:1822-8; discussion 1828-9. 10.1016/j.athoracsur.2012.03.004
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2012.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22551847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=The%20role%20of%20adjuvant%20radiation%20therapy%20for%20resected%20stage%20III%20thymoma:%20a%20population-based%20study.&amp;author=B%20Weksler&amp;author=M%20Shende&amp;author=KS%20Nason&amp;volume=93&amp;publication_year=2012&amp;pages=1822-8&amp;pmid=22551847&amp;doi=10.1016/j.athoracsur.2012.03.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r21">
<span class="label">21.</span><cite>Mariano C, Ionescu DN, Cheung WY, et al.
Thymoma: a population-based study of the management and outcomes for the province of British Columbia.
J Thorac Oncol
2013;8:109-17. 10.1097/JTO.0b013e318276241c
</cite> [<a href="https://doi.org/10.1097/JTO.0b013e318276241c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23242441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Thymoma:%20a%20population-based%20study%20of%20the%20management%20and%20outcomes%20for%20the%20province%20of%20British%20Columbia.&amp;author=C%20Mariano&amp;author=DN%20Ionescu&amp;author=WY%20Cheung&amp;volume=8&amp;publication_year=2013&amp;pages=109-17&amp;pmid=23242441&amp;doi=10.1097/JTO.0b013e318276241c&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r22">
<span class="label">22.</span><cite>Ruffini E, Detterbeck F, Van Raemdonck D, et al.
Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database.
J Thorac Oncol
2014;9:541-8. 10.1097/JTO.0000000000000128
</cite> [<a href="https://doi.org/10.1097/JTO.0000000000000128" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24736078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Thymic%20carcinoma:%20a%20cohort%20study%20of%20patients%20from%20the%20European%20society%20of%20thoracic%20surgeons%20database.&amp;author=E%20Ruffini&amp;author=F%20Detterbeck&amp;author=D%20Van%20Raemdonck&amp;volume=9&amp;publication_year=2014&amp;pages=541-8&amp;pmid=24736078&amp;doi=10.1097/JTO.0000000000000128&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r23">
<span class="label">23.</span><cite>Omasa M, Date H, Sozu T, et al.
Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
Cancer
2015;121:1008-16. 10.1002/cncr.29166
</cite> [<a href="https://doi.org/10.1002/cncr.29166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25565590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Postoperative%20radiotherapy%20is%20effective%20for%20thymic%20carcinoma%20but%20not%20for%20thymoma%20in%20stage%20II%20and%20III%20thymic%20epithelial%20tumors:%20the%20Japanese%20Association%20for%20Research%20on%20the%20Thymus%20Database%20Study.&amp;author=M%20Omasa&amp;author=H%20Date&amp;author=T%20Sozu&amp;volume=121&amp;publication_year=2015&amp;pages=1008-16&amp;pmid=25565590&amp;doi=10.1002/cncr.29166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r24">
<span class="label">24.</span><cite>Hishida T, Nomura S, Yano M, et al.
Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study.
Eur J Cardiothorac Surg
2016;49:835-41. 10.1093/ejcts/ezv239
</cite> [<a href="https://doi.org/10.1093/ejcts/ezv239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26116920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cardiothorac%20Surg&amp;title=Long-term%20outcome%20and%20prognostic%20factors%20of%20surgically%20treated%20thymic%20carcinoma:%20results%20of%20306%20cases%20from%20a%20Japanese%20Nationwide%20Database%20Study.&amp;author=T%20Hishida&amp;author=S%20Nomura&amp;author=M%20Yano&amp;volume=49&amp;publication_year=2016&amp;pages=835-41&amp;pmid=26116920&amp;doi=10.1093/ejcts/ezv239&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r25">
<span class="label">25.</span><cite>Lim YJ, Kim HJ, Wu HG. Role of Postoperative Radiotherapy in Nonlocalized Thymoma: Propensity-Matched Analysis of Surveillance, Epidemiology, and End Results Database.
J Thorac Oncol
2015;10:1357-63. 10.1097/JTO.0000000000000619
</cite> [<a href="https://doi.org/10.1097/JTO.0000000000000619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26280586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Role%20of%20Postoperative%20Radiotherapy%20in%20Nonlocalized%20Thymoma:%20Propensity-Matched%20Analysis%20of%20Surveillance,%20Epidemiology,%20and%20End%20Results%20Database.&amp;author=YJ%20Lim&amp;author=HJ%20Kim&amp;author=HG%20Wu&amp;volume=10&amp;publication_year=2015&amp;pages=1357-63&amp;pmid=26280586&amp;doi=10.1097/JTO.0000000000000619&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r26">
<span class="label">26.</span><cite>Fu H, Gu ZT, Fang WT, et al.
Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma Database.
Ann Surg Oncol
2016;23:619-25. 10.1245/s10434-015-4825-4
</cite> [<a href="https://doi.org/10.1245/s10434-015-4825-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26474558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Surg%20Oncol&amp;title=Long-Term%20Survival%20After%20Surgical%20Treatment%20of%20Thymic%20Carcinoma:%20A%20Retrospective%20Analysis%20from%20the%20Chinese%20Alliance%20for%20Research%20of%20Thymoma%20Database.&amp;author=H%20Fu&amp;author=ZT%20Gu&amp;author=WT%20Fang&amp;volume=23&amp;publication_year=2016&amp;pages=619-25&amp;pmid=26474558&amp;doi=10.1245/s10434-015-4825-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r27">
<span class="label">27.</span><cite>Wang F, Pang L, Fu J, et al.
Postoperative survival for patients with thymoma complicating myasthenia gravis-preliminary retrospective results of the ChART database.
J Thorac Dis
2016;8:711-7. 10.21037/jtd.2016.02.07
</cite> [<a href="https://doi.org/10.21037/jtd.2016.02.07" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4824728/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27114839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Dis&amp;title=Postoperative%20survival%20for%20patients%20with%20thymoma%20complicating%20myasthenia%20gravis-preliminary%20retrospective%20results%20of%20the%20ChART%20database.&amp;author=F%20Wang&amp;author=L%20Pang&amp;author=J%20Fu&amp;volume=8&amp;publication_year=2016&amp;pages=711-7&amp;pmid=27114839&amp;doi=10.21037/jtd.2016.02.07&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r28">
<span class="label">28.</span><cite>Liu Q, Gu Z, Yang F, et al.
The role of postoperative radiotherapy for stage I/II/III thymic tumor-results of the ChART retrospective database.
J Thorac Dis
2016;8:687-95. 10.21037/jtd.2016.03.28
</cite> [<a href="https://doi.org/10.21037/jtd.2016.03.28" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4824725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27114836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Dis&amp;title=The%20role%20of%20postoperative%20radiotherapy%20for%20stage%20I/II/III%20thymic%20tumor-results%20of%20the%20ChART%20retrospective%20database.&amp;author=Q%20Liu&amp;author=Z%20Gu&amp;author=F%20Yang&amp;volume=8&amp;publication_year=2016&amp;pages=687-95&amp;pmid=27114836&amp;doi=10.21037/jtd.2016.03.28&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r29">
<span class="label">29.</span><cite>Rimner A, Yao X, Huang J, et al.
Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma-An Analysis of the International Thymic Malignancies Interest Group Retrospective Database.
J Thorac Oncol
2016;11:1785-92. 10.1016/j.jtho.2016.06.011
</cite> [<a href="https://doi.org/10.1016/j.jtho.2016.06.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5257334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27346413/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Postoperative%20Radiation%20Therapy%20Is%20Associated%20with%20Longer%20Overall%20Survival%20in%20Completely%20Resected%20Stage%20II%20and%20III%20Thymoma-An%20Analysis%20of%20the%20International%20Thymic%20Malignancies%20Interest%20Group%20Retrospective%20Database.&amp;author=A%20Rimner&amp;author=X%20Yao&amp;author=J%20Huang&amp;volume=11&amp;publication_year=2016&amp;pages=1785-92&amp;pmid=27346413&amp;doi=10.1016/j.jtho.2016.06.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r30">
<span class="label">30.</span><cite>Jackson MW, Palma DA, Camidge DR, et al.
The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma.
J Thorac Oncol
2017;12:734-44. 10.1016/j.jtho.2017.01.002
</cite> [<a href="https://doi.org/10.1016/j.jtho.2017.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28126540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=The%20Impact%20of%20Postoperative%20Radiotherapy%20for%20Thymoma%20and%20Thymic%20Carcinoma.&amp;author=MW%20Jackson&amp;author=DA%20Palma&amp;author=DR%20Camidge&amp;volume=12&amp;publication_year=2017&amp;pages=734-44&amp;pmid=28126540&amp;doi=10.1016/j.jtho.2017.01.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r31">
<span class="label">31.</span><cite>Lim YJ, Song C, Kim JS. Improved survival with postoperative radiotherapy in thymic carcinoma: A propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database.
Lung Cancer
2017;108:161-7. 10.1016/j.lungcan.2017.03.020
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2017.03.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28625630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&amp;title=Improved%20survival%20with%20postoperative%20radiotherapy%20in%20thymic%20carcinoma:%20A%20propensity-matched%20analysis%20of%20Surveillance,%20Epidemiology,%20and%20End%20Results%20(SEER)%20database.&amp;author=YJ%20Lim&amp;author=C%20Song&amp;author=JS%20Kim&amp;volume=108&amp;publication_year=2017&amp;pages=161-7&amp;pmid=28625630&amp;doi=10.1016/j.lungcan.2017.03.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r32">
<span class="label">32.</span><cite>Mou H, Liao Q, Hou X, et al.
Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988-2013).
Int J Radiat Biol
2018;94:495-502. 10.1080/09553002.2018.1454618
</cite> [<a href="https://doi.org/10.1080/09553002.2018.1454618" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29553917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Biol&amp;title=Clinical%20characteristics,%20risk%20factors,%20and%20outcomes%20after%20adjuvant%20radiotherapy%20for%20patients%20with%20thymoma%20in%20the%20United%20States:%20analysis%20of%20the%20Surveillance,%20Epidemiology,%20and%20End%20Results%20(SEER)%20Registry%20(1988-2013).&amp;author=H%20Mou&amp;author=Q%20Liao&amp;author=X%20Hou&amp;volume=94&amp;publication_year=2018&amp;pages=495-502&amp;pmid=29553917&amp;doi=10.1080/09553002.2018.1454618&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r33">
<span class="label">33.</span><cite>Bian D, Zhou F, Yang W, et al.
Thymoma size significantly affects the survival, metastasis and effectiveness of adjuvant therapies: a population based study.
Oncotarget
2018;9:12273-83. 10.18632/oncotarget.24315
</cite> [<a href="https://doi.org/10.18632/oncotarget.24315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5844745/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29552309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Thymoma%20size%20significantly%20affects%20the%20survival,%20metastasis%20and%20effectiveness%20of%20adjuvant%20therapies:%20a%20population%20based%20study.&amp;author=D%20Bian&amp;author=F%20Zhou&amp;author=W%20Yang&amp;volume=9&amp;publication_year=2018&amp;pages=12273-83&amp;pmid=29552309&amp;doi=10.18632/oncotarget.24315&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r34">
<span class="label">34.</span><cite>Gu Z, Chen C, Wang Y, et al.
Video-assisted thoracoscopic surgery versus open surgery for Stage I thymic epithelial tumours: a propensity score-matched study.
Eur J Cardiothorac Surg
2018;54:1037-44. 10.1093/ejcts/ezy239
</cite> [<a href="https://doi.org/10.1093/ejcts/ezy239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30016438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Cardiothorac%20Surg&amp;title=Video-assisted%20thoracoscopic%20surgery%20versus%20open%20surgery%20for%20Stage%20I%20thymic%20epithelial%20tumours:%20a%20propensity%20score-matched%20study.&amp;author=Z%20Gu&amp;author=C%20Chen&amp;author=Y%20Wang&amp;volume=54&amp;publication_year=2018&amp;pages=1037-44&amp;pmid=30016438&amp;doi=10.1093/ejcts/ezy239&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r35">
<span class="label">35.</span><cite>Kim S, Bull DA, Hsu CH, et al.
The Role of Adjuvant Therapy in Advanced Thymic Carcinoma: A National Cancer Database Analysis.
Ann Thorac Surg
2020;109:1095-103. 10.1016/j.athoracsur.2019.11.009
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2019.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31877285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=The%20Role%20of%20Adjuvant%20Therapy%20in%20Advanced%20Thymic%20Carcinoma:%20A%20National%20Cancer%20Database%20Analysis.&amp;author=S%20Kim&amp;author=DA%20Bull&amp;author=CH%20Hsu&amp;volume=109&amp;publication_year=2020&amp;pages=1095-103&amp;pmid=31877285&amp;doi=10.1016/j.athoracsur.2019.11.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r36">
<span class="label">36.</span><cite>Mou H, Kong Y, Wu Y, et al.
Effect of Postoperative Radiotherapy in Thymoma Patients: A SEER-Based Study.
Oncol Res Treat
2021;44:28-35. 10.1159/000508311
</cite> [<a href="https://doi.org/10.1159/000508311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33311030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Res%20Treat&amp;title=Effect%20of%20Postoperative%20Radiotherapy%20in%20Thymoma%20Patients:%20A%20SEER-Based%20Study.&amp;author=H%20Mou&amp;author=Y%20Kong&amp;author=Y%20Wu&amp;volume=44&amp;publication_year=2021&amp;pages=28-35&amp;pmid=33311030&amp;doi=10.1159/000508311&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r37">
<span class="label">37.</span><cite>Wu J, Wang Z, Jing C, et al.
The incidence and prognosis of thymic squamous cell carcinoma: A Surveillance, Epidemiology, and End Results Program population-based study.
Medicine (Baltimore)
2021;100:e25331. 10.1097/MD.0000000000025331
</cite> [<a href="https://doi.org/10.1097/MD.0000000000025331" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8052076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33847631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicine%20(Baltimore)&amp;title=The%20incidence%20and%20prognosis%20of%20thymic%20squamous%20cell%20carcinoma:%20A%20Surveillance,%20Epidemiology,%20and%20End%20Results%20Program%20population-based%20study.&amp;author=J%20Wu&amp;author=Z%20Wang&amp;author=C%20Jing&amp;volume=100&amp;publication_year=2021&amp;pages=e25331&amp;pmid=33847631&amp;doi=10.1097/MD.0000000000025331&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r38">
<span class="label">38.</span><cite>Muslim Z, Baig MZ, Weber JF, et al.
Invasive thymoma - Which patients benefit from post-operative radiotherapy?
Asian Cardiovasc Thorac Ann
2021;29:935-42. 10.1177/02184923211017094
</cite> [<a href="https://doi.org/10.1177/02184923211017094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33975467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Cardiovasc%20Thorac%20Ann&amp;title=Invasive%20thymoma%20-%20Which%20patients%20benefit%20from%20post-operative%20radiotherapy?&amp;author=Z%20Muslim&amp;author=MZ%20Baig&amp;author=JF%20Weber&amp;volume=29&amp;publication_year=2021&amp;pages=935-42&amp;pmid=33975467&amp;doi=10.1177/02184923211017094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r39">
<span class="label">39.</span><cite>Lococo F, Nachira D, Chiappetta M, et al.
Does Myasthenia Gravis Affect Long-Term Survival in Thymic Carcinomas? An ESTS Database Analysis.
Diagnostics (Basel)
2022;12:1764. 10.3390/diagnostics12071764
</cite> [<a href="https://doi.org/10.3390/diagnostics12071764" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9319380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35885668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostics%20(Basel)&amp;title=Does%20Myasthenia%20Gravis%20Affect%20Long-Term%20Survival%20in%20Thymic%20Carcinomas?%20An%20ESTS%20Database%20Analysis.&amp;author=F%20Lococo&amp;author=D%20Nachira&amp;author=M%20Chiappetta&amp;volume=12&amp;publication_year=2022&amp;pages=1764&amp;pmid=35885668&amp;doi=10.3390/diagnostics12071764&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r40">
<span class="label">40.</span><cite>Zhang C, Wang Q, Hu L, et al.
The Prognostic Value of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma: A Propensity-Matched Study Based on SEER Database.
Cancers (Basel)
2022;14:4938. 10.3390/cancers14194938
</cite> [<a href="https://doi.org/10.3390/cancers14194938" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9563976/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36230861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=The%20Prognostic%20Value%20of%20Postoperative%20Radiotherapy%20for%20Thymoma%20and%20Thymic%20Carcinoma:%20A%20Propensity-Matched%20Study%20Based%20on%20SEER%20Database.&amp;author=C%20Zhang&amp;author=Q%20Wang&amp;author=L%20Hu&amp;volume=14&amp;publication_year=2022&amp;pages=4938&amp;pmid=36230861&amp;doi=10.3390/cancers14194938&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r41">
<span class="label">41.</span><cite>Lin LM, Li YM, Huang YX, et al.
Evaluation of the role of postoperative radiotherapy in locally invasive thymoma: A propensity-matched study based on the SEER database.
PLoS One
2023;18:e0283192. 10.1371/journal.pone.0283192
</cite> [<a href="https://doi.org/10.1371/journal.pone.0283192" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10101529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37053227/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Evaluation%20of%20the%20role%20of%20postoperative%20radiotherapy%20in%20locally%20invasive%20thymoma:%20A%20propensity-matched%20study%20based%20on%20the%20SEER%20database.&amp;author=LM%20Lin&amp;author=YM%20Li&amp;author=YX%20Huang&amp;volume=18&amp;publication_year=2023&amp;pages=e0283192&amp;pmid=37053227&amp;doi=10.1371/journal.pone.0283192&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r42">
<span class="label">42.</span><cite>Ma J, Sun X, Huang L, et al.
Postoperative radiotherapy and tumor recurrence after complete resection of stage II/III thymic tumor: a meta-analysis of cohort studies.
Onco Targets Ther
2016;9:4517-26. 10.2147/OTT.S104435
</cite> [<a href="https://doi.org/10.2147/OTT.S104435" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4966637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27524907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Onco%20Targets%20Ther&amp;title=Postoperative%20radiotherapy%20and%20tumor%20recurrence%20after%20complete%20resection%20of%20stage%20II/III%20thymic%20tumor:%20a%20meta-analysis%20of%20cohort%20studies.&amp;author=J%20Ma&amp;author=X%20Sun&amp;author=L%20Huang&amp;volume=9&amp;publication_year=2016&amp;pages=4517-26&amp;pmid=27524907&amp;doi=10.2147/OTT.S104435&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r43">
<span class="label">43.</span><cite>Korst RJ, Kansler AL, Christos PJ, et al.
Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis.
Ann Thorac Surg
2009;87:1641-7. 10.1016/j.athoracsur.2008.11.022
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2008.11.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19379938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=Adjuvant%20radiotherapy%20for%20thymic%20epithelial%20tumors:%20a%20systematic%20review%20and%20meta-analysis.&amp;author=RJ%20Korst&amp;author=AL%20Kansler&amp;author=PJ%20Christos&amp;volume=87&amp;publication_year=2009&amp;pages=1641-7&amp;pmid=19379938&amp;doi=10.1016/j.athoracsur.2008.11.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r44">
<span class="label">44.</span><cite>Zhou D, Deng XF, Liu QX, et al.
The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis.
Ann Thorac Surg
2016;101:305-10. 10.1016/j.athoracsur.2015.06.034
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2015.06.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26363651/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=The%20Effectiveness%20of%20Postoperative%20Radiotherapy%20in%20Patients%20With%20Completely%20Resected%20Thymoma:%20A%20Meta-Analysis.&amp;author=D%20Zhou&amp;author=XF%20Deng&amp;author=QX%20Liu&amp;volume=101&amp;publication_year=2016&amp;pages=305-10&amp;pmid=26363651&amp;doi=10.1016/j.athoracsur.2015.06.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r45">
<span class="label">45.</span><cite>Tateishi Y, Horita N, Namkoong H, et al.
Postoperative Radiotherapy for Completely Resected Masaoka/Masaoka-Koga Stage II/III Thymoma Improves Overall Survival: An Updated Meta-Analysis of 4746 Patients.
J Thorac Oncol
2021;16:677-85. 10.1016/j.jtho.2020.12.023
</cite> [<a href="https://doi.org/10.1016/j.jtho.2020.12.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33515812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Postoperative%20Radiotherapy%20for%20Completely%20Resected%20Masaoka/Masaoka-Koga%20Stage%20II/III%20Thymoma%20Improves%20Overall%20Survival:%20An%20Updated%20Meta-Analysis%20of%204746%20Patients.&amp;author=Y%20Tateishi&amp;author=N%20Horita&amp;author=H%20Namkoong&amp;volume=16&amp;publication_year=2021&amp;pages=677-85&amp;pmid=33515812&amp;doi=10.1016/j.jtho.2020.12.023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r46">
<span class="label">46.</span><cite>Hamaji M, Shah RM, Ali SO, et al.
A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma.
Ann Thorac Surg
2017;103:1668-75. 10.1016/j.athoracsur.2016.12.042
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2016.12.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28366466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=A%20Meta-Analysis%20of%20Postoperative%20Radiotherapy%20for%20Thymic%20Carcinoma.&amp;author=M%20Hamaji&amp;author=RM%20Shah&amp;author=SO%20Ali&amp;volume=103&amp;publication_year=2017&amp;pages=1668-75&amp;pmid=28366466&amp;doi=10.1016/j.athoracsur.2016.12.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r47">
<span class="label">47.</span><cite>Rimner A, Ruffini E, Cilento V, et al.
The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: An Overview of the Central Database Informing Revision of the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.
J Thorac Oncol
2023;18:1386-98. 10.1016/j.jtho.2023.07.008
</cite> [<a href="https://doi.org/10.1016/j.jtho.2023.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37702630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=The%20International%20Association%20for%20the%20Study%20of%20Lung%20Cancer%20Thymic%20Epithelial%20Tumors%20Staging%20Project:%20An%20Overview%20of%20the%20Central%20Database%20Informing%20Revision%20of%20the%20Forthcoming%20(Ninth)%20Edition%20of%20the%20TNM%20Classification%20of%20Malignant%20Tumors.&amp;author=A%20Rimner&amp;author=E%20Ruffini&amp;author=V%20Cilento&amp;volume=18&amp;publication_year=2023&amp;pages=1386-98&amp;pmid=37702630&amp;doi=10.1016/j.jtho.2023.07.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r48">
<span class="label">48.</span><cite>Aprile V, Bertoglio P, Korasidis S, et al.
Nerve-Sparing Surgery in Advanced Stage Thymomas.
Ann Thorac Surg
2019;107:878-84. 10.1016/j.athoracsur.2018.08.071
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2018.08.071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30336118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=Nerve-Sparing%20Surgery%20in%20Advanced%20Stage%20Thymomas.&amp;author=V%20Aprile&amp;author=P%20Bertoglio&amp;author=S%20Korasidis&amp;volume=107&amp;publication_year=2019&amp;pages=878-84&amp;pmid=30336118&amp;doi=10.1016/j.athoracsur.2018.08.071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r49">
<span class="label">49.</span><cite>Khandelwal A, Sholl LM, Araki T, et al.
Patterns of metastasis and recurrence in thymic epithelial tumours: longitudinal imaging review in correlation with histological subtypes.
Clin Radiol
2016;71:1010-7. 10.1016/j.crad.2016.05.007
</cite> [<a href="https://doi.org/10.1016/j.crad.2016.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5010483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27267746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Radiol&amp;title=Patterns%20of%20metastasis%20and%20recurrence%20in%20thymic%20epithelial%20tumours:%20longitudinal%20imaging%20review%20in%20correlation%20with%20histological%20subtypes.&amp;author=A%20Khandelwal&amp;author=LM%20Sholl&amp;author=T%20Araki&amp;volume=71&amp;publication_year=2016&amp;pages=1010-7&amp;pmid=27267746&amp;doi=10.1016/j.crad.2016.05.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r50">
<span class="label">50.</span><cite>Huang J, Rizk NP, Travis WD, et al.
Comparison of patterns of relapse in thymic carcinoma and thymoma.
J Thorac Cardiovasc Surg
2009;138:26-31. 10.1016/j.jtcvs.2009.03.033
</cite> [<a href="https://doi.org/10.1016/j.jtcvs.2009.03.033" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4151511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19577051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Cardiovasc%20Surg&amp;title=Comparison%20of%20patterns%20of%20relapse%20in%20thymic%20carcinoma%20and%20thymoma.&amp;author=J%20Huang&amp;author=NP%20Rizk&amp;author=WD%20Travis&amp;volume=138&amp;publication_year=2009&amp;pages=26-31&amp;pmid=19577051&amp;doi=10.1016/j.jtcvs.2009.03.033&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r51">
<span class="label">51.</span><cite>Zhai Y, Hui Z, Gao Y, et al.
Debulking Surgery Plus Radiation: Treatment Choice for Unresectable Stage III Thymic Carcinoma.
Thorac Cardiovasc Surg
2020;68:440-5. 10.1055/s-0039-1688723
</cite> [<a href="https://doi.org/10.1055/s-0039-1688723" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31140185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thorac%20Cardiovasc%20Surg&amp;title=Debulking%20Surgery%20Plus%20Radiation:%20Treatment%20Choice%20for%20Unresectable%20Stage%20III%20Thymic%20Carcinoma.&amp;author=Y%20Zhai&amp;author=Z%20Hui&amp;author=Y%20Gao&amp;volume=68&amp;publication_year=2020&amp;pages=440-5&amp;pmid=31140185&amp;doi=10.1055/s-0039-1688723&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r52">
<span class="label">52.</span><cite>Mastromarino MG, Bacchin D, Aprile V, et al.
Unradical Surgery for Locally-Advanced Thymoma: Is it time to evolve Perspectives?
Lung Cancer
2023;180:107214. 10.1016/j.lungcan.2023.107214
</cite> [<a href="https://doi.org/10.1016/j.lungcan.2023.107214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37104878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lung%20Cancer&amp;title=Unradical%20Surgery%20for%20Locally-Advanced%20Thymoma:%20Is%20it%20time%20to%20evolve%20Perspectives?&amp;author=MG%20Mastromarino&amp;author=D%20Bacchin&amp;author=V%20Aprile&amp;volume=180&amp;publication_year=2023&amp;pages=107214&amp;pmid=37104878&amp;doi=10.1016/j.lungcan.2023.107214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r53">
<span class="label">53.</span><cite>Rimner A, Gomez DR, Wu AJ, et al.
Failure patterns relative to radiation treatment fields for stage II-IV thymoma.
J Thorac Oncol
2014;9:403-9. 10.1097/JTO.0000000000000099
</cite> [<a href="https://doi.org/10.1097/JTO.0000000000000099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24518091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Failure%20patterns%20relative%20to%20radiation%20treatment%20fields%20for%20stage%20II-IV%20thymoma.&amp;author=A%20Rimner&amp;author=DR%20Gomez&amp;author=AJ%20Wu&amp;volume=9&amp;publication_year=2014&amp;pages=403-9&amp;pmid=24518091&amp;doi=10.1097/JTO.0000000000000099&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r54">
<span class="label">54.</span><cite>Carretta A, Ciriaco P, Muriana P, et al.
Surgical treatment of single and multiple thymoma recurrences.
Gen Thorac Cardiovasc Surg
2020;68:350-6. 10.1007/s11748-019-01229-w
</cite> [<a href="https://doi.org/10.1007/s11748-019-01229-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31637673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gen%20Thorac%20Cardiovasc%20Surg&amp;title=Surgical%20treatment%20of%20single%20and%20multiple%20thymoma%20recurrences.&amp;author=A%20Carretta&amp;author=P%20Ciriaco&amp;author=P%20Muriana&amp;volume=68&amp;publication_year=2020&amp;pages=350-6&amp;pmid=31637673&amp;doi=10.1007/s11748-019-01229-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r55">
<span class="label">55.</span><cite>Ciccone AM, Rendina EA. Treatment of recurrent thymic tumors.
Semin Thorac Cardiovasc Surg
2005;17:27-31. 10.1053/j.semtcvs.2004.12.004
</cite> [<a href="https://doi.org/10.1053/j.semtcvs.2004.12.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16104358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Semin%20Thorac%20Cardiovasc%20Surg&amp;title=Treatment%20of%20recurrent%20thymic%20tumors.&amp;author=AM%20Ciccone&amp;author=EA%20Rendina&amp;volume=17&amp;publication_year=2005&amp;pages=27-31&amp;pmid=16104358&amp;doi=10.1053/j.semtcvs.2004.12.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r56">
<span class="label">56.</span><cite>Haniuda M, Kondo R, Numanami H, et al.
Recurrence of thymoma: clinicopathological features, re-operation, and outcome.
J Surg Oncol
2001;78:183-8. 10.1002/jso.1146
</cite> [<a href="https://doi.org/10.1002/jso.1146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11745803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Surg%20Oncol&amp;title=Recurrence%20of%20thymoma:%20clinicopathological%20features,%20re-operation,%20and%20outcome.&amp;author=M%20Haniuda&amp;author=R%20Kondo&amp;author=H%20Numanami&amp;volume=78&amp;publication_year=2001&amp;pages=183-8&amp;pmid=11745803&amp;doi=10.1002/jso.1146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r57">
<span class="label">57.</span><cite>Sandri A, Cusumano G, Lococo F, et al.
Long-term results after treatment for recurrent thymoma: a multicenter analysis.
J Thorac Oncol
2014;9:1796-804. 10.1097/JTO.0000000000000370
</cite> [<a href="https://doi.org/10.1097/JTO.0000000000000370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25393792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Long-term%20results%20after%20treatment%20for%20recurrent%20thymoma:%20a%20multicenter%20analysis.&amp;author=A%20Sandri&amp;author=G%20Cusumano&amp;author=F%20Lococo&amp;volume=9&amp;publication_year=2014&amp;pages=1796-804&amp;pmid=25393792&amp;doi=10.1097/JTO.0000000000000370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r58">
<span class="label">58.</span><cite>Zucali PA, De Pas T, Palmieri G, et al.
Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.
J Clin Oncol
2018;36:342-9. 10.1200/JCO.2017.74.4078
</cite> [<a href="https://doi.org/10.1200/JCO.2017.74.4078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29240542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Phase%20II%20Study%20of%20Everolimus%20in%20Patients%20With%20Thymoma%20and%20Thymic%20Carcinoma%20Previously%20Treated%20With%20Cisplatin-Based%20Chemotherapy.&amp;author=PA%20Zucali&amp;author=T%20De%20Pas&amp;author=G%20Palmieri&amp;volume=36&amp;publication_year=2018&amp;pages=342-9&amp;pmid=29240542&amp;doi=10.1200/JCO.2017.74.4078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r59">
<span class="label">59.</span><cite>Sato J, Satouchi M, Itoh S, et al.
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial.
Lancet Oncol
2020;21:843-50. 10.1016/S1470-2045(20)30162-5
</cite> [<a href="https://doi.org/10.1016/S1470-2045(20)30162-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32502444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Lenvatinib%20in%20patients%20with%20advanced%20or%20metastatic%20thymic%20carcinoma%20(REMORA):%20a%20multicentre,%20phase%202%20trial.&amp;author=J%20Sato&amp;author=M%20Satouchi&amp;author=S%20Itoh&amp;volume=21&amp;publication_year=2020&amp;pages=843-50&amp;pmid=32502444&amp;doi=10.1016/S1470-2045(20)30162-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r60">
<span class="label">60.</span><cite>Thomas A, Rajan A, Berman A, et al.
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Lancet Oncol
2015;16:177-86. 10.1016/S1470-2045(14)71181-7
</cite> [<a href="https://doi.org/10.1016/S1470-2045(14)71181-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4401497/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25592632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Sunitinib%20in%20patients%20with%20chemotherapy-refractory%20thymoma%20and%20thymic%20carcinoma:%20an%20open-label%20phase%202%20trial.&amp;author=A%20Thomas&amp;author=A%20Rajan&amp;author=A%20Berman&amp;volume=16&amp;publication_year=2015&amp;pages=177-86&amp;pmid=25592632&amp;doi=10.1016/S1470-2045(14)71181-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r61">
<span class="label">61.</span><cite>Girard N, Ruffini E, Marx A, et al.
Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
2015;26
Suppl 5:v40-55. 10.1093/annonc/mdv277
</cite> [<a href="https://doi.org/10.1093/annonc/mdv277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26314779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Oncol&amp;title=Thymic%20epithelial%20tumours:%20ESMO%20Clinical%20Practice%20Guidelines%20for%20diagnosis,%20treatment%20and%20follow-up.&amp;author=N%20Girard&amp;author=E%20Ruffini&amp;author=A%20Marx&amp;volume=26&amp;issue=Suppl%205&amp;publication_year=2015&amp;pages=v40-55&amp;pmid=26314779&amp;doi=10.1093/annonc/mdv277&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r62">
<span class="label">62.</span><cite>Chun SG, Rimner A, Amini A, et al.
American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma.
JAMA Oncol
2023;9:971-80. 10.1001/jamaoncol.2023.1175
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2023.1175" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11665036/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37186595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=American%20Radium%20Society%20Appropriate%20Use%20Criteria%20for%20Radiation%20Therapy%20in%20the%20Multidisciplinary%20Management%20of%20Thymic%20Carcinoma.&amp;author=SG%20Chun&amp;author=A%20Rimner&amp;author=A%20Amini&amp;volume=9&amp;publication_year=2023&amp;pages=971-80&amp;pmid=37186595&amp;doi=10.1001/jamaoncol.2023.1175&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r63">
<span class="label">63.</span><cite>Haefner MF, Verma V, Bougatf N, et al.
Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
Acta Oncol
2018;57:1713-20. 10.1080/0284186X.2018.1502467
</cite> [<a href="https://doi.org/10.1080/0284186X.2018.1502467" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30264630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncol&amp;title=Dosimetric%20comparison%20of%20advanced%20radiotherapy%20approaches%20using%20photon%20techniques%20and%20particle%20therapy%20in%20the%20postoperative%20management%20of%20thymoma.&amp;author=MF%20Haefner&amp;author=V%20Verma&amp;author=N%20Bougatf&amp;volume=57&amp;publication_year=2018&amp;pages=1713-20&amp;pmid=30264630&amp;doi=10.1080/0284186X.2018.1502467&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r64">
<span class="label">64.</span><cite>Holliday E, Fuller CD, Kalpathy-Cramer J, et al.
Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.
J Radiat Oncol
2016;5:55-61. 10.1007/s13566-015-0230-7
</cite> [<a href="https://doi.org/10.1007/s13566-015-0230-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4996619/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27570583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Radiat%20Oncol&amp;title=Quantitative%20assessment%20of%20target%20delineation%20variability%20for%20thymic%20cancers:%20Agreement%20evaluation%20of%20a%20prospective%20segmentation%20challenge.&amp;author=E%20Holliday&amp;author=CD%20Fuller&amp;author=J%20Kalpathy-Cramer&amp;volume=5&amp;publication_year=2016&amp;pages=55-61&amp;pmid=27570583&amp;doi=10.1007/s13566-015-0230-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r65">
<span class="label">65.</span><cite>Kondo K, Monden Y. Lymphogenous and hematogenous metastasis of thymic epithelial tumors.
Ann Thorac Surg
2003;76:1859-64; discussion 1864-5. 10.1016/S0003-4975(03)01017-8
</cite> [<a href="https://doi.org/10.1016/S0003-4975(03)01017-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14667600/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=Lymphogenous%20and%20hematogenous%20metastasis%20of%20thymic%20epithelial%20tumors.&amp;author=K%20Kondo&amp;author=Y%20Monden&amp;volume=76&amp;publication_year=2003&amp;pages=1859-64&amp;pmid=14667600&amp;doi=10.1016/S0003-4975(03)01017-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r66">
<span class="label">66.</span><cite>Kim YJ, Kim SS, Song SY, et al.
Elective Nodal Irradiation as Adjuvant Radiotherapy for Advanced Thymomas and Thymic Carcinomas.
Clin Lung Cancer
2019;20:e91-6. 10.1016/j.cllc.2018.09.007
</cite> [<a href="https://doi.org/10.1016/j.cllc.2018.09.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30327246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Lung%20Cancer&amp;title=Elective%20Nodal%20Irradiation%20as%20Adjuvant%20Radiotherapy%20for%20Advanced%20Thymomas%20and%20Thymic%20Carcinomas.&amp;author=YJ%20Kim&amp;author=SS%20Kim&amp;author=SY%20Song&amp;volume=20&amp;publication_year=2019&amp;pages=e91-6&amp;pmid=30327246&amp;doi=10.1016/j.cllc.2018.09.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r67">
<span class="label">67.</span><cite>National Comprehensive Cancer Network. Non-small cell lung cancer (Version 3.2023). Available online: <a href="https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</a></cite>
</li>
<li id="r68">
<span class="label">68.</span><cite>Vogel J, Lin L, Simone CB, 2nd, et al.
Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies.
Acta Oncol
2017;56:1060-4. 10.1080/0284186X.2017.1302097
</cite> [<a href="https://doi.org/10.1080/0284186X.2017.1302097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28338373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncol&amp;title=Risk%20of%20major%20cardiac%20events%20following%20adjuvant%20proton%20versus%20photon%20radiation%20therapy%20for%20patients%20with%20thymic%20malignancies.&amp;author=J%20Vogel&amp;author=L%20Lin&amp;author=CB%20Simone&amp;volume=56&amp;publication_year=2017&amp;pages=1060-4&amp;pmid=28338373&amp;doi=10.1080/0284186X.2017.1302097&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r69">
<span class="label">69.</span><cite>Vogel J, Lin L, Litzky LA, et al.
Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
Int J Radiat Oncol Biol Phys
2017;99:427-33. 10.1016/j.ijrobp.2017.04.022
</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2017.04.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28871993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Predicted%20Rate%20of%20Secondary%20Malignancies%20Following%20Adjuvant%20Proton%20Versus%20Photon%20Radiation%20Therapy%20for%20Thymoma.&amp;author=J%20Vogel&amp;author=L%20Lin&amp;author=LA%20Litzky&amp;volume=99&amp;publication_year=2017&amp;pages=427-33&amp;pmid=28871993&amp;doi=10.1016/j.ijrobp.2017.04.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r70">
<span class="label">70.</span><cite>Zhu HJ, Hoppe BS, Flampouri S, et al.
Rationale and early outcomes for the management of thymoma with proton therapy.
Transl Lung Cancer Res
2018;7:106-13. 10.21037/tlcr.2018.04.06
</cite> [<a href="https://doi.org/10.21037/tlcr.2018.04.06" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5960651/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29876309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Lung%20Cancer%20Res&amp;title=Rationale%20and%20early%20outcomes%20for%20the%20management%20of%20thymoma%20with%20proton%20therapy.&amp;author=HJ%20Zhu&amp;author=BS%20Hoppe&amp;author=S%20Flampouri&amp;volume=7&amp;publication_year=2018&amp;pages=106-13&amp;pmid=29876309&amp;doi=10.21037/tlcr.2018.04.06&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r71">
<span class="label">71.</span><cite>Parikh RR, Rhome R, Hug E, et al.
Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Clin Lung Cancer
2016;17:362-6. 10.1016/j.cllc.2016.05.019
</cite> [<a href="https://doi.org/10.1016/j.cllc.2016.05.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27372386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Lung%20Cancer&amp;title=Adjuvant%20Proton%20Beam%20Therapy%20in%20the%20Management%20of%20Thymoma:%20A%20Dosimetric%20Comparison%20and%20Acute%20Toxicities.&amp;author=RR%20Parikh&amp;author=R%20Rhome&amp;author=E%20Hug&amp;volume=17&amp;publication_year=2016&amp;pages=362-6&amp;pmid=27372386&amp;doi=10.1016/j.cllc.2016.05.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r72">
<span class="label">72.</span><cite>Franceschini D, Cozzi L, Loi M, et al.
Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.
J Cancer Res Clin Oncol
2020;146:2267-76. 10.1007/s00432-020-03281-z
</cite> [<a href="https://doi.org/10.1007/s00432-020-03281-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11804366/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32514629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cancer%20Res%20Clin%20Oncol&amp;title=Volumetric%20modulated%20arc%20therapy%20versus%20intensity-modulated%20proton%20therapy%20in%20the%20postoperative%20irradiation%20of%20thymoma.&amp;author=D%20Franceschini&amp;author=L%20Cozzi&amp;author=M%20Loi&amp;volume=146&amp;publication_year=2020&amp;pages=2267-76&amp;pmid=32514629&amp;doi=10.1007/s00432-020-03281-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r73">
<span class="label">73.</span><cite>Vogel J, Berman AT, Lin L, et al.
Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: Early response and toxicity assessment.
Radiother Oncol
2016;118:504-9. 10.1016/j.radonc.2016.02.003
</cite> [<a href="https://doi.org/10.1016/j.radonc.2016.02.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26895711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiother%20Oncol&amp;title=Prospective%20study%20of%20proton%20beam%20radiation%20therapy%20for%20adjuvant%20and%20definitive%20treatment%20of%20thymoma%20and%20thymic%20carcinoma:%20Early%20response%20and%20toxicity%20assessment.&amp;author=J%20Vogel&amp;author=AT%20Berman&amp;author=L%20Lin&amp;volume=118&amp;publication_year=2016&amp;pages=504-9&amp;pmid=26895711&amp;doi=10.1016/j.radonc.2016.02.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r74">
<span class="label">74.</span><cite>Mercado CE, Hartsell WF, Simone CB, 2nd, et al.
Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.
Acta Oncol
2019;58:1036-40. 10.1080/0284186X.2019.1575981
</cite> [<a href="https://doi.org/10.1080/0284186X.2019.1575981" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30784340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncol&amp;title=Proton%20therapy%20for%20thymic%20malignancies:%20multi-institutional%20patterns-of-care%20and%20early%20clinical%20outcomes%20from%20the%20proton%20collaborative%20group%20and%20the%20university%20of%20Florida%20prospective%20registries.&amp;author=CE%20Mercado&amp;author=WF%20Hartsell&amp;author=CB%20Simone&amp;volume=58&amp;publication_year=2019&amp;pages=1036-40&amp;pmid=30784340&amp;doi=10.1080/0284186X.2019.1575981&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r75">
<span class="label">75.</span><cite>Tsujino K, Hashimoto T, Shimada T, et al.
Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
J Thorac Oncol
2014;9:983-90. 10.1097/JTO.0000000000000187
</cite> [<a href="https://doi.org/10.1097/JTO.0000000000000187" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24922010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;title=Combined%20analysis%20of%20V20,%20VS5,%20pulmonary%20fibrosis%20score%20on%20baseline%20computed%20tomography,%20and%20patient%20age%20improves%20prediction%20of%20severe%20radiation%20pneumonitis%20after%20concurrent%20chemoradiotherapy%20for%20locally%20advanced%20non-small-cell%20lung%20cancer.&amp;author=K%20Tsujino&amp;author=T%20Hashimoto&amp;author=T%20Shimada&amp;volume=9&amp;publication_year=2014&amp;pages=983-90&amp;pmid=24922010&amp;doi=10.1097/JTO.0000000000000187&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r76">
<span class="label">76.</span><cite>Barriger RB, Fakiris AJ, Hanna N, et al.
Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
Int J Radiat Oncol Biol Phys
2010;78:1381-6. 10.1016/j.ijrobp.2009.09.030
</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2009.09.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20231061/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Dose-volume%20analysis%20of%20radiation%20pneumonitis%20in%20non-small-cell%20lung%20cancer%20patients%20treated%20with%20concurrent%20cisplatinum%20and%20etoposide%20with%20or%20without%20consolidation%20docetaxel.&amp;author=RB%20Barriger&amp;author=AJ%20Fakiris&amp;author=N%20Hanna&amp;volume=78&amp;publication_year=2010&amp;pages=1381-6&amp;pmid=20231061&amp;doi=10.1016/j.ijrobp.2009.09.030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r77">
<span class="label">77.</span><cite>Moiseenko V, Craig T, Bezjak A, et al.
Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: a retrospective review.
Radiother Oncol
2003;67:265-74. 10.1016/S0167-8140(03)00003-3
</cite> [<a href="https://doi.org/10.1016/S0167-8140(03)00003-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12865174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiother%20Oncol&amp;title=Dose-volume%20analysis%20of%20lung%20complications%20in%20the%20radiation%20treatment%20of%20malignant%20thymoma:%20a%20retrospective%20review.&amp;author=V%20Moiseenko&amp;author=T%20Craig&amp;author=A%20Bezjak&amp;volume=67&amp;publication_year=2003&amp;pages=265-74&amp;pmid=12865174&amp;doi=10.1016/S0167-8140(03)00003-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r78">
<span class="label">78.</span><cite>Tomita N, Okuda K, Ogawa Y, et al.
Relationship between radiation doses to heart substructures and radiation pneumonitis in patients with thymic epithelial tumors.
Sci Rep
2020;10:11191. 10.1038/s41598-020-68168-y
</cite> [<a href="https://doi.org/10.1038/s41598-020-68168-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7340766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32636439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Relationship%20between%20radiation%20doses%20to%20heart%20substructures%20and%20radiation%20pneumonitis%20in%20patients%20with%20thymic%20epithelial%20tumors.&amp;author=N%20Tomita&amp;author=K%20Okuda&amp;author=Y%20Ogawa&amp;volume=10&amp;publication_year=2020&amp;pages=11191&amp;pmid=32636439&amp;doi=10.1038/s41598-020-68168-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r79">
<span class="label">79.</span><cite>Darby SC, Ewertz M, McGale P, et al.
Risk of ischemic heart disease in women after radiotherapy for breast cancer.
N Engl J Med
2013;368:987-98. 10.1056/NEJMoa1209825
</cite> [<a href="https://doi.org/10.1056/NEJMoa1209825" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23484825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Risk%20of%20ischemic%20heart%20disease%20in%20women%20after%20radiotherapy%20for%20breast%20cancer.&amp;author=SC%20Darby&amp;author=M%20Ewertz&amp;author=P%20McGale&amp;volume=368&amp;publication_year=2013&amp;pages=987-98&amp;pmid=23484825&amp;doi=10.1056/NEJMoa1209825&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r80">
<span class="label">80.</span><cite>Hamaji M, Sozu T, Machida R, et al.
Second malignancy versus recurrence after complete resection of thymoma.
Asian Cardiovasc Thorac Ann
2018;26:290-5. 10.1177/0218492318765872
</cite> [<a href="https://doi.org/10.1177/0218492318765872" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29528688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Cardiovasc%20Thorac%20Ann&amp;title=Second%20malignancy%20versus%20recurrence%20after%20complete%20resection%20of%20thymoma.&amp;author=M%20Hamaji&amp;author=T%20Sozu&amp;author=R%20Machida&amp;volume=26&amp;publication_year=2018&amp;pages=290-5&amp;pmid=29528688&amp;doi=10.1177/0218492318765872&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r81">
<span class="label">81.</span><cite>Jalbout W, Jbara R, Rizk C, et al.
On the risk of secondary cancer from thymoma radiotherapy.
Phys Med Biol
2022. 10.1088/1361-6560/ac7c50
</cite> [<a href="https://doi.org/10.1088/1361-6560/ac7c50" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35876010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phys%20Med%20Biol&amp;title=On%20the%20risk%20of%20secondary%20cancer%20from%20thymoma%20radiotherapy.&amp;author=W%20Jalbout&amp;author=R%20Jbara&amp;author=C%20Rizk&amp;publication_year=2022&amp;pmid=35876010&amp;doi=10.1088/1361-6560/ac7c50&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r82">
<span class="label">82.</span><cite>Pan CC, Chen PC, Wang LS, et al.
Thymoma is associated with an increased risk of second malignancy.
Cancer
2001;92:2406-11.
</cite> [<a href="https://doi.org/10.1002/1097-0142(20011101)92:9&amp;#x0003c;2406::AID-CNCR1589&amp;#x0003e;3.0.CO;2-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11745297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Thymoma%20is%20associated%20with%20an%20increased%20risk%20of%20second%20malignancy.&amp;author=CC%20Pan&amp;author=PC%20Chen&amp;author=LS%20Wang&amp;volume=92&amp;publication_year=2001&amp;pages=2406-11&amp;pmid=11745297&amp;doi=10.1002/1097-0142(20011101)92:9&amp;#x0003c;2406::AID-CNCR1589&amp;#x0003e;3.0.CO;2-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r83">
<span class="label">83.</span><cite>Hamaji M, Kawaguchi A, Omasa M, et al.
Low incidence of and mortality from a second malignancy after resection of thymic carcinoma†.
Interact Cardiovasc Thorac Surg
2019;28:375-9. 10.1093/icvts/ivy260
</cite> [<a href="https://doi.org/10.1093/icvts/ivy260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30137401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Interact%20Cardiovasc%20Thorac%20Surg&amp;title=Low%20incidence%20of%20and%20mortality%20from%20a%20second%20malignancy%20after%20resection%20of%20thymic%20carcinoma%E2%80%A0.&amp;author=M%20Hamaji&amp;author=A%20Kawaguchi&amp;author=M%20Omasa&amp;volume=28&amp;publication_year=2019&amp;pages=375-9&amp;pmid=30137401&amp;doi=10.1093/icvts/ivy260&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r84">
<span class="label">84.</span><cite>Roden AC, Ahmad U, Cardillo G, et al. Thymic Carcinomas-A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group . J Thorac Oncol
2022;17:637-50. 10.1016/j.jtho.2022.01.021
</cite> [<a href="https://doi.org/10.1016/j.jtho.2022.01.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11080660/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35227908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Oncol&amp;author=AC%20Roden&amp;author=U%20Ahmad&amp;author=G%20Cardillo&amp;volume=17&amp;publication_year=2022&amp;pages=637-50&amp;pmid=35227908&amp;doi=10.1016/j.jtho.2022.01.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r85">
<span class="label">85.</span><cite>Basse C, Botticella A, Molina TJ, et al.
RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection.
Clin Lung Cancer
2021;22:469-72. 10.1016/j.cllc.2021.01.020
</cite> [<a href="https://doi.org/10.1016/j.cllc.2021.01.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33736940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Lung%20Cancer&amp;title=RADIORYTHMIC:%20Phase%20III,%20Opened,%20Randomized%20Study%20of%20Postoperative%20Radiotherapy%20Versus%20Surveillance%20in%20Stage%20IIb/III%20of%20Masaoka%20Koga%20Thymoma%20after%20Complete%20Surgical%20Resection.&amp;author=C%20Basse&amp;author=A%20Botticella&amp;author=TJ%20Molina&amp;volume=22&amp;publication_year=2021&amp;pages=469-72&amp;pmid=33736940&amp;doi=10.1016/j.cllc.2021.01.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r86">
<span class="label">86.</span><cite>Rimner A, Zauderer MG, Gomez DR, et al.
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.
J Clin Oncol
2016;34:2761-8. 10.1200/JCO.2016.67.2675
</cite> [<a href="https://doi.org/10.1200/JCO.2016.67.2675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5019761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27325859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Phase%20II%20Study%20of%20Hemithoracic%20Intensity-Modulated%20Pleural%20Radiation%20Therapy%20(IMPRINT)%20As%20Part%20of%20Lung-Sparing%20Multimodality%20Therapy%20in%20Patients%20With%20Malignant%20Pleural%20Mesothelioma.&amp;author=A%20Rimner&amp;author=MG%20Zauderer&amp;author=DR%20Gomez&amp;volume=34&amp;publication_year=2016&amp;pages=2761-8&amp;pmid=27325859&amp;doi=10.1200/JCO.2016.67.2675&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r87">
<span class="label">87.</span><cite>Kamel MK, Stiles BM, Ghaly G, et al.
Predictors of Pleural Implants in Patients With Thymic Tumors.
Ann Thorac Surg
2016;102:1647-52. 10.1016/j.athoracsur.2016.04.026
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2016.04.026" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27324527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Thorac%20Surg&amp;title=Predictors%20of%20Pleural%20Implants%20in%20Patients%20With%20Thymic%20Tumors.&amp;author=MK%20Kamel&amp;author=BM%20Stiles&amp;author=G%20Ghaly&amp;volume=102&amp;publication_year=2016&amp;pages=1647-52&amp;pmid=27324527&amp;doi=10.1016/j.athoracsur.2016.04.026&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r88">
<span class="label">88.</span><cite>Palma DA, Olson R, Harrow S, et al.
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.
Lancet
2019;393:2051-8. 10.1016/S0140-6736(18)32487-5
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)32487-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30982687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Stereotactic%20ablative%20radiotherapy%20versus%20standard%20of%20care%20palliative%20treatment%20in%20patients%20with%20oligometastatic%20cancers%20(SABR-COMET):%20a%20randomised,%20phase%202,%20open-label%20trial.&amp;author=DA%20Palma&amp;author=R%20Olson&amp;author=S%20Harrow&amp;volume=393&amp;publication_year=2019&amp;pages=2051-8&amp;pmid=30982687&amp;doi=10.1016/S0140-6736(18)32487-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r89">
<span class="label">89.</span><cite>Yano M, Sasaki H, Moriyama S, et al.
Number of recurrent lesions is a prognostic factor in recurrent thymoma.
Interact Cardiovasc Thorac Surg
2011;13:21-4. 10.1510/icvts.2010.264036
</cite> [<a href="https://doi.org/10.1510/icvts.2010.264036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21454313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Interact%20Cardiovasc%20Thorac%20Surg&amp;title=Number%20of%20recurrent%20lesions%20is%20a%20prognostic%20factor%20in%20recurrent%20thymoma.&amp;author=M%20Yano&amp;author=H%20Sasaki&amp;author=S%20Moriyama&amp;volume=13&amp;publication_year=2011&amp;pages=21-4&amp;pmid=21454313&amp;doi=10.1510/icvts.2010.264036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r90">
<span class="label">90.</span><cite>Schwarz M, Cattaneo GM, Marrazzo L. Geometrical and dosimetrical uncertainties in hypofractionated radiotherapy of the lung: A review.
Phys Med
2017;36:126-39. 10.1016/j.ejmp.2017.02.011
</cite> [<a href="https://doi.org/10.1016/j.ejmp.2017.02.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28238577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phys%20Med&amp;title=Geometrical%20and%20dosimetrical%20uncertainties%20in%20hypofractionated%20radiotherapy%20of%20the%20lung:%20A%20review.&amp;author=M%20Schwarz&amp;author=GM%20Cattaneo&amp;author=L%20Marrazzo&amp;volume=36&amp;publication_year=2017&amp;pages=126-39&amp;pmid=28238577&amp;doi=10.1016/j.ejmp.2017.02.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r91">
<span class="label">91.</span><cite>Rohrer Bley C, Meier V, Schneider U.
Dosimetric benefit of adaptive radiotherapy in the neoadjuvant management of canine and feline thymoma-An exploratory case series.
Vet Comp Oncol
2018;16:324-9. 10.1111/vco.12382
</cite> [<a href="https://doi.org/10.1111/vco.12382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29316134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vet%20Comp%20Oncol&amp;title=Dosimetric%20benefit%20of%20adaptive%20radiotherapy%20in%20the%20neoadjuvant%20management%20of%20canine%20and%20feline%20thymoma-An%20exploratory%20case%20series.&amp;author=C%20Rohrer%20Bley&amp;author=V%20Meier&amp;author=U.%20Schneider&amp;volume=16&amp;publication_year=2018&amp;pages=324-9&amp;pmid=29316134&amp;doi=10.1111/vco.12382&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r92">
<span class="label">92.</span><cite>McCready JE, Poirier VJ, Fleck A, et al.
Adaptive radiation therapy using weekly hypofractionation for thymoma treatment: A retrospective study of 10 rabbits.
Vet Comp Oncol
2022;20:559-67. 10.1111/vco.12807
</cite> [<a href="https://doi.org/10.1111/vco.12807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35212142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Vet%20Comp%20Oncol&amp;title=Adaptive%20radiation%20therapy%20using%20weekly%20hypofractionation%20for%20thymoma%20treatment:%20A%20retrospective%20study%20of%2010%20rabbits.&amp;author=JE%20McCready&amp;author=VJ%20Poirier&amp;author=A%20Fleck&amp;volume=20&amp;publication_year=2022&amp;pages=559-67&amp;pmid=35212142&amp;doi=10.1111/vco.12807&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r93">
<span class="label">93.</span><cite>Kokubo M, Nishimura Y, Shibamoto Y, et al.
Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer.
Int J Radiat Oncol Biol Phys
2000;48:1081-7. 10.1016/S0360-3016(00)00673-8
</cite> [<a href="https://doi.org/10.1016/S0360-3016(00)00673-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11072166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Analysis%20of%20the%20clinical%20benefit%20of%20intraoperative%20radiotherapy%20in%20patients%20undergoing%20macroscopically%20curative%20resection%20for%20pancreatic%20cancer.&amp;author=M%20Kokubo&amp;author=Y%20Nishimura&amp;author=Y%20Shibamoto&amp;volume=48&amp;publication_year=2000&amp;pages=1081-7&amp;pmid=11072166&amp;doi=10.1016/S0360-3016(00)00673-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r94">
<span class="label">94.</span><cite>Oya N, Kokubo M, Mizowaki T, et al.
Definitive intraoperative very high-dose radiotherapy for localized osteosarcoma in the extremities.
Int J Radiat Oncol Biol Phys
2001;51:87-93. 10.1016/S0360-3016(01)01603-0
</cite> [<a href="https://doi.org/10.1016/S0360-3016(01)01603-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11516856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Definitive%20intraoperative%20very%20high-dose%20radiotherapy%20for%20localized%20osteosarcoma%20in%20the%20extremities.&amp;author=N%20Oya&amp;author=M%20Kokubo&amp;author=T%20Mizowaki&amp;volume=51&amp;publication_year=2001&amp;pages=87-93&amp;pmid=11516856&amp;doi=10.1016/S0360-3016(01)01603-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r95">
<span class="label">95.</span><cite>Cui TX, Dai JG, Li JM, et al.
Safety and efficacy of INTRABEAM intraoperative radiotherapy for invasive thymoma.
Medicine (Baltimore)
2020;99:e20964. 10.1097/MD.0000000000020964
</cite> [<a href="https://doi.org/10.1097/MD.0000000000020964" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7337413/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32629705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicine%20(Baltimore)&amp;title=Safety%20and%20efficacy%20of%20INTRABEAM%20intraoperative%20radiotherapy%20for%20invasive%20thymoma.&amp;author=TX%20Cui&amp;author=JG%20Dai&amp;author=JM%20Li&amp;volume=99&amp;publication_year=2020&amp;pages=e20964&amp;pmid=32629705&amp;doi=10.1097/MD.0000000000020964&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r96">
<span class="label">96.</span><cite>Salfity HV, Timsina L, Ceppa DP, et al.
Minimally invasive surgery in the management of resectable thymoma: a retrospective analysis from the National Cancer Database.
J Thorac Dis
2021;13:6353-62. 10.21037/jtd-20-2660
</cite> [<a href="https://doi.org/10.21037/jtd-20-2660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8662507/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34992815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Thorac%20Dis&amp;title=Minimally%20invasive%20surgery%20in%20the%20management%20of%20resectable%20thymoma:%20a%20retrospective%20analysis%20from%20the%20National%20Cancer%20Database.&amp;author=HV%20Salfity&amp;author=L%20Timsina&amp;author=DP%20Ceppa&amp;volume=13&amp;publication_year=2021&amp;pages=6353-62&amp;pmid=34992815&amp;doi=10.21037/jtd-20-2660&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r97">
<span class="label">97.</span><cite>Lesueur P, Chevalier F, Stefan D, et al.
Review of the mechanisms involved in the abscopal effect and future directions with a focus on thymic carcinoma.
Tumori
2017;103:217-22. 10.5301/tj.5000616
</cite> [<a href="https://doi.org/10.5301/tj.5000616" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28291902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Tumori&amp;title=Review%20of%20the%20mechanisms%20involved%20in%20the%20abscopal%20effect%20and%20future%20directions%20with%20a%20focus%20on%20thymic%20carcinoma.&amp;author=P%20Lesueur&amp;author=F%20Chevalier&amp;author=D%20Stefan&amp;volume=103&amp;publication_year=2017&amp;pages=217-22&amp;pmid=28291902&amp;doi=10.5301/tj.5000616&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r98">
<span class="label">98.</span><cite>Zhang YS, Zhang YH, Li XJ, et al.
Bystander effect and abscopal effect in recurrent thymic carcinoma treated with carbon-ion radiation therapy: A case report.
World J Clin Cases
2021;9:6538-43. 10.12998/wjcc.v9.i22.6538
</cite> [<a href="https://doi.org/10.12998/wjcc.v9.i22.6538" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8362568/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34435023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J%20Clin%20Cases&amp;title=Bystander%20effect%20and%20abscopal%20effect%20in%20recurrent%20thymic%20carcinoma%20treated%20with%20carbon-ion%20radiation%20therapy:%20A%20case%20report.&amp;author=YS%20Zhang&amp;author=YH%20Zhang&amp;author=XJ%20Li&amp;volume=9&amp;publication_year=2021&amp;pages=6538-43&amp;pmid=34435023&amp;doi=10.12998/wjcc.v9.i22.6538&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r99">
<span class="label">99.</span><cite>Mole RH. Whole body irradiation; radiobiology or medicine?
Br J Radiol
1953;26:234-41. 10.1259/0007-1285-26-305-234
</cite> [<a href="https://doi.org/10.1259/0007-1285-26-305-234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/13042090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Radiol&amp;title=Whole%20body%20irradiation;%20radiobiology%20or%20medicine?&amp;author=RH%20Mole&amp;volume=26&amp;publication_year=1953&amp;pages=234-41&amp;pmid=13042090&amp;doi=10.1259/0007-1285-26-305-234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="r100">
<span class="label">100.</span><cite>Demaria S, Ng B, Devitt ML, et al.
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.
Int J Radiat Oncol Biol Phys
2004;58:862-70. 10.1016/j.ijrobp.2003.09.012
</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2003.09.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14967443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&amp;title=Ionizing%20radiation%20inhibition%20of%20distant%20untreated%20tumors%20(abscopal%20effect)%20is%20immune%20mediated.&amp;author=S%20Demaria&amp;author=B%20Ng&amp;author=ML%20Devitt&amp;volume=58&amp;publication_year=2004&amp;pages=862-70&amp;pmid=14967443&amp;doi=10.1016/j.ijrobp.2003.09.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="med-08-40-prf"><section class="pmc-layout__citation font-secondary font-xs"><div>Mediastinum.</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Peer Review File</h1></hgroup><ul class="d-buttons inline-list"><li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li></ul>
<div class="d-panels font-secondary-light"><div id="clp_a.c" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div></div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<p>Available at <a href="https://med.amegroups.com/article/view/10.21037/med-23-38/prf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://med.amegroups.com/article/view/10.21037/med-23-38/prf</a></p>
<figure class="fig xbox font-sm" id="d67e4753"><div class="media p"><div class="caption">
<a href="/articles/instance/11330913/bin/med-08-40-prf.pdf" data-ga-action="click_feat_suppl" class="usa-link">med-08-40-prf.pdf</a><sup> (92.7KB, pdf) </sup>
</div></div>
<div class="p text-right font-secondary"><a href="figure/d67e4753/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>The article’s supplementary files as</p></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p">
<div class="caption">
<a href="/articles/instance/11330913/bin/med-08-40-rc.pdf" data-ga-action="click_feat_suppl" class="usa-link">med-08-40-rc.pdf</a><sup> (97.9KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/med-23-38</div>
</div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/11330913/bin/med-08-40-coif.pdf" data-ga-action="click_feat_suppl" class="usa-link">med-08-40-coif.pdf</a><sup> (116.6KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.21037/med-23-38</div>
</div></section></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Mediastinum are provided here courtesy of <strong>AME Publications</strong></p></footer></section></article>



                    </main>
                </div>
            </div>
        </div>





<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">

               <li>
                     <a
                             href="https://doi.org/10.21037/med-23-38"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>


               <li>
                    <a
                            href="pdf/med-08-40.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (212.9 KB)</span>
                    </a>
               </li>


               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11330913/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11330913/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>

               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11330913%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>


<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11330913/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11330913/">
            <h2 class="margin-top-0">RESOURCES</h2>

                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11330913/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"

                                data-source-url="/resources/similar-article-links/39161587/"

                    >

                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11330913/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"

                                data-source-url="/resources/cited-by-links/39161587/"

                    >

                    </div>

                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11330913/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11330913/"
                        >
                        </div>


                </div>

        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>




<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>



<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>


<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >

      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>

      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>

      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>

      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>

  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">



<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="EiXgNEIfQ31Yly53oQwgc6WbnYjzZUCbYX5zWQPvZ8DFcn48ZBdcWmpSP879ZsSf">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>



      </div>
    </div>
  </div>







<footer class="ncbi-footer ncbi-dark-background " >

        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">

                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>



                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>



                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>



                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>



                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>

            </div>
        </div>


    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">

                <div class="ncbi-footer__column">

                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>


                    <div class="ncbi-footer__circled-icons-list">

                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>



                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>



                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>

                    </div>
                </div>



                <address class="ncbi-footer__address ncbi-footer__column">

        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>

                </address>



                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">

                        <li class="ncbi-footer__vertical-list-item">










    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >



            Web Policies



    </a>


                        </li>

                        <li class="ncbi-footer__vertical-list-item">










    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >



            FOIA



    </a>


                        </li>

                        <li class="ncbi-footer__vertical-list-item">










    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >



            HHS Vulnerability Disclosure



    </a>


                        </li>

                </ul>



                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">

                        <li class="ncbi-footer__vertical-list-item">










    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >



            Help



    </a>


                        </li>

                        <li class="ncbi-footer__vertical-list-item">










    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >



            Accessibility



    </a>


                        </li>

                        <li class="ncbi-footer__vertical-list-item">










    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >



            Careers



    </a>


                        </li>

                </ul>

        </div>


            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">

                        <li class="ncbi-footer__bottom-list-item">










    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >



            NLM



    </a>


                        </li>

                        <li class="ncbi-footer__bottom-list-item">










    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >



            NIH



    </a>


                        </li>

                        <li class="ncbi-footer__bottom-list-item">










    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >



            HHS



    </a>


                        </li>

                        <li class="ncbi-footer__bottom-list-item">










    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >



            USA.gov



    </a>


                        </li>

                </ul>
            </div>

    </div>
</footer>







  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>





<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>








    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',

        staticEndpoint: '/static/',

        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>

    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>



    </body>
</html>
